ccdd_code,ccdd_formal_name,ccdd_type,policy_type,policy_reference,special_groupings_status,special_groupings_status_effective_time
"8000006","testosterone","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000010","methylphenidate","TM","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000023","acetaminophen and caffeine and codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000045","oxycodone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000045","oxycodone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000048","diazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000059","acetaminophen and oxycodone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000059","acetaminophen and oxycodone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000061","clonazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000065","acetaminophen and codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000069","codeine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000069","codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000071","morphine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000071","morphine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000079","oxazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000087","temazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000088","alprazolam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000090","bromazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000091","flurazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000106","hydromorphone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000106","hydromorphone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000109","lorazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000127","fentanyl","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000127","fentanyl","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000162","dextroamphetamine","TM","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000238","clobazam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000285","methadone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000285","methadone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000349","acetaminophen and tramadol","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000369","tramadol","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000372","buprenorphine and naloxone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000372","buprenorphine and naloxone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000387","lisdexamfetamine","TM","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000774","acetylsalicylic acid and oxycodone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000774","acetylsalicylic acid and oxycodone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000775","buprenorphine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000775","buprenorphine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000776","butorphanol","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000776","butorphanol","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000777","hydrocodone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000777","hydrocodone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000778","hydrocodone and phenyltoloxamine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000778","hydrocodone and phenyltoloxamine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000779","alcohol anhydrous and doxylamine and etafedrin and hydrocodone and sodium citrate","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000779","alcohol anhydrous and doxylamine and etafedrin and hydrocodone and sodium citrate","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000780","brompheniramine and guaifenesin and hydrocodone and phenylephrine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000780","brompheniramine and guaifenesin and hydrocodone and phenylephrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000781","hydrocodone and phenylephrine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000781","hydrocodone and phenylephrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000782","meperidine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000782","meperidine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000783","naloxone and oxycodone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000783","naloxone and oxycodone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000784","normethadone and p-hydroxyephedrine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000784","normethadone and p-hydroxyephedrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000785","belladonna and opium","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000785","belladonna and opium","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000786","pentazocine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000786","pentazocine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000788","belladonna and ergotamine and phenobarbital","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000789","tapentadol","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"8000789","tapentadol","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000799","phenobarbital","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000805","acetylsalicylic acid and butalbital and caffeine and codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000806","acetylsalicylic acid and caffeine and codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000808","acetylsalicylic acid and butalbital and caffeine","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000828","acetaminophen and codeine and doxylamine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000854","acetaminophen and chlorzoxazone and codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000859","acetaminophen and codeine and methocarbamol","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000861","acetylsalicylic acid and codeine and methocarbamol","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000925","brompheniramine and codeine and phenylephrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8000926","brompheniramine and codeine and guaifenesin and phenylephrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001092","nitrazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001093","nabilone","TM","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001095","triazolam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001107","midazolam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001121","zolpidem","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001350","chlordiazepoxide","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001351","chlordiazepoxide and clidinium","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001361","clorazepate","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001364","codeine and guaifenesin and pseudoephedrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001403","nalbuphine","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001572","atropine and diphenoxylate","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001692","ammonium chloride and codeine and diphenhydramine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001900","codeine and guaifenesin and pheniramine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001920","remifentanil","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001940","sodium oxybate","TM","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8001947","sufentanil","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8002028","ketamine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8002112","codeine and guaifenesin and pseudoephedrine and triprolidine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8002113","codeine and pseudoephedrine and triprolidine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"8002225","amphetamine mixed salts","TM","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"31146dc35e00dbd79882eeabbf1b7259","buprenorphine 100 mg per 0.5 mL prolonged-release solution for injection syringe","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"31146dc35e00dbd79882eeabbf1b7259","buprenorphine 100 mg per 0.5 mL prolonged-release solution for injection syringe","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"37915ed5c648cb4a1357ea94fc019dc5","buprenorphine 300 mg per 1.5 mL prolonged-release solution for injection syringe","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"37915ed5c648cb4a1357ea94fc019dc5","buprenorphine 300 mg per 1.5 mL prolonged-release solution for injection syringe","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000001","meperidine hydrochloride 50 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000001","meperidine hydrochloride 50 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000010","testosterone cypionate 1000 mg per 10 mL solution for injection vial","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000013","testosterone enanthate 1000 mg per 5 mL solution for injection ampoule","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000015","methylphenidate hydrochloride 10 mg oral tablet","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000016","hydrocodone 5 mg and phenyltoloxamine 10 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000016","hydrocodone 5 mg and phenyltoloxamine 10 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000017","hydrocodone 5 mg per 5 mL and phenyltoloxamine 10 mg per 5 mL oral suspension","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000017","hydrocodone 5 mg per 5 mL and phenyltoloxamine 10 mg per 5 mL oral suspension","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000023","methylphenidate hydrochloride 20 mg oral tablet","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000031","acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 15 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000032","acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 30 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000051","pentazocine (pentazocine hydrochloride) 50 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000051","pentazocine (pentazocine hydrochloride) 50 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000069","oxycodone hydrochloride 10 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000069","oxycodone hydrochloride 10 mg suppository","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000070","oxycodone hydrochloride 20 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000070","oxycodone hydrochloride 20 mg suppository","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000075","diazepam 5 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000083","acetaminophen 325 mg and caffeine citrate 30 mg and codeine phosphate 15 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000084","acetaminophen 325 mg and caffeine citrate 30 mg and codeine phosphate 30 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000085","acetaminophen 325 mg and caffeine citrate 30 mg and codeine phosphate 8 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000094","acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000094","acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000097","clonazepam 0.5 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000098","clonazepam 2 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000103","acetaminophen 300 mg and codeine phosphate 60 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000107","codeine phosphate 30 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000107","codeine phosphate 30 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000108","diazepam 10 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000111","morphine sulfate 15 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000111","morphine sulfate 15 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000128","diazepam 2 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000135","oxazepam 10 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000136","oxazepam 15 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000137","oxazepam 30 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000153","oxycodone hydrochloride 10 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000153","oxycodone hydrochloride 10 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000157","temazepam 15 mg oral capsule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000158","temazepam 30 mg oral capsule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000161","alprazolam 0.25 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000162","alprazolam 0.5 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000164","bromazepam 3 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000165","bromazepam 6 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000166","codeine phosphate 60 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000166","codeine phosphate 60 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000168","flurazepam hydrochloride 15 mg oral capsule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000169","flurazepam hydrochloride 30 mg oral capsule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000181","codeine phosphate 15 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000181","codeine phosphate 15 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000182","codeine phosphate 30 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000182","codeine phosphate 30 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000194","acetaminophen 300 mg and codeine phosphate 30 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000195","acetylsalicylic acid 325 mg and oxycodone hydrochloride 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000195","acetylsalicylic acid 325 mg and oxycodone hydrochloride 5 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000201","hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000201","hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000202","hydromorphone hydrochloride 2 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000202","hydromorphone hydrochloride 2 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000203","hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000203","hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000204","hydromorphone hydrochloride 4 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000204","hydromorphone hydrochloride 4 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000206","hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000206","hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000208","methylphenidate hydrochloride 20 mg prolonged-release oral tablet","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000209","morphine hydrochloride 1 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000209","morphine hydrochloride 1 mg per mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000210","morphine sulfate 1 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000210","morphine sulfate 1 mg per mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000211","morphine sulfate 20 mg per mL oral drops","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000211","morphine sulfate 20 mg per mL oral drops","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000224","lorazepam 0.5 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000225","lorazepam 1 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000226","lorazepam 2 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000228","morphine hydrochloride 5 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000228","morphine hydrochloride 5 mg per mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000229","morphine sulfate 10 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000229","morphine sulfate 10 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000230","morphine sulfate 10 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000230","morphine sulfate 10 mg suppository","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000231","morphine sulfate 20 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000231","morphine sulfate 20 mg suppository","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000232","morphine sulfate 25 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000232","morphine sulfate 25 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000233","morphine sulfate 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000233","morphine sulfate 5 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000243","acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000253","hydromorphone hydrochloride 1 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000253","hydromorphone hydrochloride 1 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000258","morphine hydrochloride 10 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000258","morphine hydrochloride 10 mg per mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000259","morphine hydrochloride 20 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000259","morphine hydrochloride 20 mg per mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000260","morphine sulfate 150 mg per 30 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000260","morphine sulfate 150 mg per 30 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000262","morphine sulfate 30 mg per 30 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000262","morphine sulfate 30 mg per 30 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000263","morphine sulfate 50 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000263","morphine sulfate 50 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000264","morphine sulfate 50 mg per mL oral drops","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000264","morphine sulfate 50 mg per mL oral drops","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000266","acetaminophen 325 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000280","morphine sulfate 10 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000280","morphine sulfate 10 mg per mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000299","morphine sulfate 10 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000299","morphine sulfate 10 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000319","fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000319","fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000320","fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000320","fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000321","fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000321","fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000322","fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000322","fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000323","fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000323","fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000324","fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000324","fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000328","hydromorphone hydrochloride 8 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000328","hydromorphone hydrochloride 8 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000331","morphine sulfate 2 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000331","morphine sulfate 2 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000362","morphine sulfate 100 mg per 4 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000362","morphine sulfate 100 mg per 4 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000364","morphine sulfate 25 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000364","morphine sulfate 25 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000365","morphine sulfate 50 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000365","morphine sulfate 50 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000367","oxycodone hydrochloride 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000367","oxycodone hydrochloride 5 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000371","acetaminophen 160 mg per 5 mL and codeine phosphate 8 mg per 5 mL oral solution","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000375","belladonna 15 mg and opium 65 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000375","belladonna 15 mg and opium 65 mg suppository","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000384","hydromorphone hydrochloride 1 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000384","hydromorphone hydrochloride 1 mg per mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000385","hydromorphone hydrochloride 3 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000385","hydromorphone hydrochloride 3 mg suppository","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000389","morphine sulfate 20 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000389","morphine sulfate 20 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000390","morphine sulfate 30 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000390","morphine sulfate 30 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000396","acetaminophen 325 mg and oxycodone hydrochloride 2.5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000396","acetaminophen 325 mg and oxycodone hydrochloride 2.5 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000397","acetaminophen 500 mg and caffeine citrate 30 mg and codeine phosphate 8 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000414","dextroamphetamine sulfate 10 mg prolonged-release oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000415","dextroamphetamine sulfate 15 mg prolonged-release oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000416","dextroamphetamine sulfate 5 mg oral tablet","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000417","diazepam 1 mg per mL oral solution","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000432","morphine sulfate 5 mg per 10 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000432","morphine sulfate 5 mg per 10 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000433","morphine sulfate 5 mg per 5 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000433","morphine sulfate 5 mg per 5 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000454","alprazolam 1 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000455","alprazolam 2 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000459","clonazepam 1 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000474","morphine sulfate 100 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000474","morphine sulfate 100 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000475","morphine sulfate 100 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000475","morphine sulfate 100 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000476","morphine sulfate 10 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000476","morphine sulfate 10 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000477","morphine sulfate 15 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000477","morphine sulfate 15 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000478","morphine sulfate 200 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000478","morphine sulfate 200 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000479","morphine sulfate 30 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000479","morphine sulfate 30 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000480","morphine sulfate 30 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000480","morphine sulfate 30 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000481","morphine sulfate 60 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000481","morphine sulfate 60 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000482","morphine sulfate 60 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000482","morphine sulfate 60 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000531","lorazepam 1 mg sublingual tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000532","lorazepam 2 mg sublingual tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000554","bromazepam 1.5 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000563","clonazepam 0.25 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000566","codeine (codeine, codeine sulfate) 100 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000566","codeine (codeine, codeine sulfate) 100 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000567","codeine (codeine, codeine sulfate) 150 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000567","codeine (codeine, codeine sulfate) 150 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000568","codeine (codeine, codeine sulfate) 200 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000568","codeine (codeine, codeine sulfate) 200 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000579","hydromorphone hydrochloride 100 mg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000579","hydromorphone hydrochloride 100 mg per 10 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000582","hydromorphone hydrochloride 250 mg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000582","hydromorphone hydrochloride 250 mg per 5 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000583","hydromorphone hydrochloride 3 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000583","hydromorphone hydrochloride 3 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000584","hydromorphone hydrochloride 500 mg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000584","hydromorphone hydrochloride 500 mg per 10 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000585","hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000585","hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000586","hydromorphone hydrochloride 6 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000586","hydromorphone hydrochloride 6 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000596","lorazepam 0.5 mg sublingual tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000617","morphine sulfate 15 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000617","morphine sulfate 15 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000618","morphine sulfate 200 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000618","morphine sulfate 200 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000664","morphine sulfate 50 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000664","morphine sulfate 50 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000665","morphine sulfate 20 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000665","morphine sulfate 20 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000679","hydromorphone hydrochloride 12 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000679","hydromorphone hydrochloride 12 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000680","hydromorphone hydrochloride 24 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000680","hydromorphone hydrochloride 24 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000695","normethadone hydrochloride 10 mg per mL and p-hydroxyephedrine hydrochloride 20 mg per mL oral drops","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000695","normethadone hydrochloride 10 mg per mL and p-hydroxyephedrine hydrochloride 20 mg per mL oral drops","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000709","codeine (codeine, codeine sulfate) 50 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000709","codeine (codeine, codeine sulfate) 50 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000711","clobazam 10 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000739","morphine sulfate 30 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000739","morphine sulfate 30 mg suppository","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000740","morphine sulfate 5 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000740","morphine sulfate 5 mg suppository","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000753","methylphenidate hydrochloride 5 mg oral tablet","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000781","hydromorphone hydrochloride 30 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000781","hydromorphone hydrochloride 30 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000879","diazepam 15 mg per 3 mL rectal gel tube","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000880","diazepam 20 mg per 4 mL rectal gel tube","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000881","diazepam 2.5 mg per 0.5 mL rectal gel tube","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000882","diazepam 5 mg per 1 mL rectal gel tube","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000883","diazepam 7.5 mg per 1.5 mL rectal gel tube","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000884","fentanyl (fentanyl citrate) 2500 mcg per 50 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000884","fentanyl (fentanyl citrate) 2500 mcg per 50 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000885","fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000885","fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000890","oxycodone hydrochloride 20 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000890","oxycodone hydrochloride 20 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000913","butorphanol tartrate 10 mg per mL nasal spray","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000913","butorphanol tartrate 10 mg per mL nasal spray","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000942","lorazepam 4 mg per 1 mL solution for injection vial","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000948","hydromorphone hydrochloride 18 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000948","hydromorphone hydrochloride 18 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9000966","hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9000966","hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001034","methadone hydrochloride 1 mg per mL oral solution","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001034","methadone hydrochloride 1 mg per mL oral solution","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001038","methylphenidate hydrochloride 18 mg prolonged-release oral tablet","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001039","methylphenidate hydrochloride 36 mg prolonged-release oral tablet","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001040","methylphenidate hydrochloride 54 mg prolonged-release oral tablet","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001041","methadone hydrochloride 10 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001041","methadone hydrochloride 10 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001042","methadone hydrochloride 1 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001042","methadone hydrochloride 1 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001043","methadone hydrochloride 25 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001043","methadone hydrochloride 25 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001044","methadone hydrochloride 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001044","methadone hydrochloride 5 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001100","methylphenidate hydrochloride 27 mg prolonged-release oral tablet","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001121","acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001161","fentanyl 100 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001161","fentanyl 100 mcg per hour transdermal patch","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001162","fentanyl 25 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001162","fentanyl 25 mcg per hour transdermal patch","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001163","fentanyl 50 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001163","fentanyl 50 mcg per hour transdermal patch","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001164","fentanyl 75 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001164","fentanyl 75 mcg per hour transdermal patch","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001165","methylphenidate hydrochloride 10 mg prolonged-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001166","methylphenidate hydrochloride 15 mg prolonged-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001167","methylphenidate hydrochloride 20 mg prolonged-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001168","methylphenidate hydrochloride 30 mg prolonged-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001169","methylphenidate hydrochloride 40 mg prolonged-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001170","methylphenidate hydrochloride 50 mg prolonged-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001171","methylphenidate hydrochloride 60 mg prolonged-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001182","tramadol hydrochloride 150 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001183","tramadol hydrochloride 200 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001184","tramadol hydrochloride 300 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001185","tramadol hydrochloride 400 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001189","methylphenidate hydrochloride 80 mg prolonged-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001207","tramadol hydrochloride 100 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001226","buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001226","buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001227","buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001227","buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001249","fentanyl 12 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001249","fentanyl 12 mcg per hour transdermal patch","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001278","lisdexamfetamine dimesylate 30 mg oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001279","lisdexamfetamine dimesylate 50 mg oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001294","testosterone undecanoate 40 mg oral capsule","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001304","hydromorphone hydrochloride 16 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001304","hydromorphone hydrochloride 16 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001305","hydromorphone hydrochloride 32 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001305","hydromorphone hydrochloride 32 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001307","hydromorphone hydrochloride 8 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001307","hydromorphone hydrochloride 8 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001310","lisdexamfetamine dimesylate 20 mg oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001311","lisdexamfetamine dimesylate 40 mg oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001312","lisdexamfetamine dimesylate 60 mg oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001315","buprenorphine 10 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001315","buprenorphine 10 mcg per hour transdermal patch","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001316","buprenorphine 20 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001316","buprenorphine 20 mcg per hour transdermal patch","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001317","buprenorphine 5 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001317","buprenorphine 5 mcg per hour transdermal patch","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001318","tramadol hydrochloride 50 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001322","naloxone hydrochloride 10 mg and oxycodone hydrochloride 20 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001322","naloxone hydrochloride 10 mg and oxycodone hydrochloride 20 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001323","naloxone hydrochloride 20 mg and oxycodone hydrochloride 40 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001323","naloxone hydrochloride 20 mg and oxycodone hydrochloride 40 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001324","naloxone hydrochloride 5 mg and oxycodone hydrochloride 10 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001324","naloxone hydrochloride 5 mg and oxycodone hydrochloride 10 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001326","fentanyl 37 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001326","fentanyl 37 mcg per hour transdermal patch","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001336","tramadol hydrochloride 75 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001340","hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001340","hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001341","hydromorphone hydrochloride 9 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001341","hydromorphone hydrochloride 9 mg prolonged-release oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001344","fentanyl (fentanyl citrate) 100 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001344","fentanyl (fentanyl citrate) 100 mcg sublingual tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001345","fentanyl (fentanyl citrate) 200 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001345","fentanyl (fentanyl citrate) 200 mcg sublingual tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001346","fentanyl (fentanyl citrate) 300 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001346","fentanyl (fentanyl citrate) 300 mcg sublingual tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001347","fentanyl (fentanyl citrate) 400 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001347","fentanyl (fentanyl citrate) 400 mcg sublingual tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001349","fentanyl (fentanyl citrate) 800 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001349","fentanyl (fentanyl citrate) 800 mcg sublingual tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001352","fentanyl (fentanyl citrate) 600 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001352","fentanyl (fentanyl citrate) 600 mcg sublingual tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001355","oxycodone hydrochloride 10 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001355","oxycodone hydrochloride 10 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001356","oxycodone hydrochloride 15 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001356","oxycodone hydrochloride 15 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001357","oxycodone hydrochloride 20 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001357","oxycodone hydrochloride 20 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001358","oxycodone hydrochloride 30 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001358","oxycodone hydrochloride 30 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001359","oxycodone hydrochloride 40 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001359","oxycodone hydrochloride 40 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001360","oxycodone hydrochloride 60 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001360","oxycodone hydrochloride 60 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001361","oxycodone hydrochloride 80 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001361","oxycodone hydrochloride 80 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001379","tramadol hydrochloride 100 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001380","tramadol hydrochloride 200 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001381","tramadol hydrochloride 300 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001391","naloxone hydrochloride 2.5 mg and oxycodone hydrochloride 5 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001391","naloxone hydrochloride 2.5 mg and oxycodone hydrochloride 5 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001392","morphine sulfate 50 mg per 5 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001392","morphine sulfate 50 mg per 5 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001393","oxycodone hydrochloride 5 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001393","oxycodone hydrochloride 5 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001395","methadone hydrochloride 10 mg per mL oral solution","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001395","methadone hydrochloride 10 mg per mL oral solution","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001424","fentanyl (fentanyl citrate) 100 mcg buccal tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001424","fentanyl (fentanyl citrate) 100 mcg buccal tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001425","fentanyl (fentanyl citrate) 200 mcg buccal tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001425","fentanyl (fentanyl citrate) 200 mcg buccal tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001426","fentanyl (fentanyl citrate) 400 mcg buccal tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001426","fentanyl (fentanyl citrate) 400 mcg buccal tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001427","fentanyl (fentanyl citrate) 600 mcg buccal tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001427","fentanyl (fentanyl citrate) 600 mcg buccal tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001428","fentanyl (fentanyl citrate) 800 mcg buccal tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001428","fentanyl (fentanyl citrate) 800 mcg buccal tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001446","lisdexamfetamine dimesylate 10 mg oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001451","lorazepam 2 mg per 1 mL solution for injection vial","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001458","testosterone 4.5 % nasal gel","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001459","buprenorphine 15 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001459","buprenorphine 15 mcg per hour transdermal patch","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001463","morphine sulfate 10 mg oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001463","morphine sulfate 10 mg oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001464","morphine sulfate 20 mg oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001464","morphine sulfate 20 mg oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001465","morphine sulfate 30 mg oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001465","morphine sulfate 30 mg oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001466","morphine sulfate 5 mg oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001466","morphine sulfate 5 mg oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001472","lisdexamfetamine dimesylate 70 mg oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001473","hydromorphone hydrochloride 100 mg per 10 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001473","hydromorphone hydrochloride 100 mg per 10 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001474","hydromorphone hydrochloride 10 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9001474","hydromorphone hydrochloride 10 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001477","diazepam 10 mg per 2 mL solution for injection ampoule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001556","phenobarbital 100 mg oral tablet","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001557","phenobarbital 15 mg oral tablet","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001558","phenobarbital 30 mg oral tablet","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001559","phenobarbital 60 mg oral tablet","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001568","belladonna 0.2 mg and ergotamine tartrate 0.6 mg and phenobarbital 40 mg prolonged-release oral tablet","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001574","atropine sulfate 0.025 mg and diphenoxylate hydrochloride 2.5 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001575","codeine phosphate 10 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001584","chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001616","phenobarbital 5 mg per mL oral solution","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001651","acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001652","acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001653","acetylsalicylic acid 375 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001668","acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001892","nitrazepam 10 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001893","nitrazepam 5 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001903","chlordiazepoxide hydrochloride 10 mg oral capsule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001904","chlordiazepoxide hydrochloride 25 mg oral capsule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001905","chlordiazepoxide hydrochloride 5 mg oral capsule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001927","acetaminophen 325 mg and codeine phosphate 8 mg and doxylamine succinate 5 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9001947","nabilone 1 mg oral capsule","NTP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002002","acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002228","triazolam 0.25 mg oral tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002269","clorazepate dipotassium 15 mg oral capsule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002270","clorazepate dipotassium 3.75 mg oral capsule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002271","clorazepate dipotassium 7.5 mg oral capsule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002331","acetaminophen 300 mg and chlorzoxazone 250 mg and codeine phosphate 8 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002403","acetaminophen 325 mg and codeine phosphate 8 mg and methocarbamol 400 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002410","acetylsalicylic acid 325 mg and codeine phosphate 16.2 mg and methocarbamol 400 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002411","acetylsalicylic acid 325 mg and codeine phosphate 32.4 mg and methocarbamol 400 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002543","codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pheniramine maleate 7.5 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002653","codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002679","hydrocodone bitartrate 1.7 mg per 5 mL and phenylephrine hydrochloride 10 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9002679","hydrocodone bitartrate 1.7 mg per 5 mL and phenylephrine hydrochloride 10 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002680","hydrocodone bitartrate 5 mg per 5 mL and phenylephrine hydrochloride 20 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9002680","hydrocodone bitartrate 5 mg per 5 mL and phenylephrine hydrochloride 20 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9002768","codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9003645","brompheniramine maleate 2 mg per 5 mL and codeine phosphate 10 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9003646","brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9003646","brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9003653","brompheniramine maleate 2 mg per 5 mL and codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9003752","ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9003937","nabilone 0.5 mg oral capsule","NTP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9004321","sodium oxybate 500 mg per mL oral solution","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9004457","nabilone 0.25 mg oral capsule","NTP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9004933","remifentanil (remifentanil hydrochloride) 1 mg per vial powder for solution for injection","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9004935","remifentanil (remifentanil hydrochloride) 2 mg per vial powder for solution for injection","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9004952","zolpidem tartrate 10 mg orodispersible tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9005007","tapentadol (tapentadol hydrochloride) 100 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9005007","tapentadol (tapentadol hydrochloride) 100 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9005008","tapentadol (tapentadol hydrochloride) 50 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9005008","tapentadol (tapentadol hydrochloride) 50 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9005009","tapentadol (tapentadol hydrochloride) 75 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9005009","tapentadol (tapentadol hydrochloride) 75 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9005166","zolpidem tartrate 5 mg orodispersible tablet","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9005492","tapentadol (tapentadol hydrochloride) 100 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9005492","tapentadol (tapentadol hydrochloride) 100 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9005493","tapentadol (tapentadol hydrochloride) 150 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9005493","tapentadol (tapentadol hydrochloride) 150 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9005494","tapentadol (tapentadol hydrochloride) 200 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9005494","tapentadol (tapentadol hydrochloride) 200 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9005495","tapentadol (tapentadol hydrochloride) 250 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9005495","tapentadol (tapentadol hydrochloride) 250 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9005496","tapentadol (tapentadol hydrochloride) 50 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9005496","tapentadol (tapentadol hydrochloride) 50 mg prolonged-release oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006199","codeine phosphate 10 mg per 5 mL oral solution","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006199","codeine phosphate 10 mg per 5 mL oral solution","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006201","alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrin hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006201","alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrin hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006204","hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006204","hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006207","codeine phosphate 25 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006207","codeine phosphate 25 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006208","meperidine hydrochloride 10 mg per mL solution for injection 30 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006208","meperidine hydrochloride 10 mg per mL solution for injection 30 mL vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006211","morphine sulfate 250 mg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006211","morphine sulfate 250 mg per 5 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006212","morphine sulfate 500 mg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006212","morphine sulfate 500 mg per 10 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006213","morphine sulfate 50 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006213","morphine sulfate 50 mg per 1 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006214","morphine sulfate 50 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006214","morphine sulfate 50 mg per mL solution for injection 50 mL vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006219","morphine sulfate 50 mg per mL solution for injection 20 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006219","morphine sulfate 50 mg per mL solution for injection 20 mL vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006223","acetaminophen 500 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006225","morphine sulfate 10 mg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006225","morphine sulfate 10 mg per 10 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006226","morphine sulfate 1 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006226","morphine sulfate 1 mg per mL solution for injection 50 mL vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006227","morphine sulfate 2 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006227","morphine sulfate 2 mg per 1 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006228","morphine sulfate 2 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006228","morphine sulfate 2 mg per mL solution for injection 50 mL vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006229","morphine sulfate 5 mg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006229","morphine sulfate 5 mg per 5 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006230","morphine sulfate 5 mg per mL solution for injection 30 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006230","morphine sulfate 5 mg per mL solution for injection 30 mL vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006243","hydromorphone hydrochloride 100 mg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006243","hydromorphone hydrochloride 100 mg per 5 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006244","hydromorphone hydrochloride 20 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006244","hydromorphone hydrochloride 20 mg per 1 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006245","hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006245","hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006271","meperidine hydrochloride 100 mg per mL solution for injection 20 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006271","meperidine hydrochloride 100 mg per mL solution for injection 20 mL vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006278","pentazocine (pentazocine lactate) 30 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006278","pentazocine (pentazocine lactate) 30 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006548","meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006548","meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006625","meperidine hydrochloride 100 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006625","meperidine hydrochloride 100 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9006626","meperidine hydrochloride 75 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9006626","meperidine hydrochloride 75 mg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9009882","hydrocodone bitartrate 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9009882","hydrocodone bitartrate 5 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9009884","hydrocodone bitartrate 5 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9009884","hydrocodone bitartrate 5 mg per 5 mL syrup","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012386","testosterone 2.5 mg per 24 hour transdermal patch","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012390","testosterone 5 mg per 24 hour transdermal patch","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012436","methylphenidate hydrochloride 25 mg modified-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012437","methylphenidate hydrochloride 35 mg modified-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012438","methylphenidate hydrochloride 45 mg modified-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012439","methylphenidate hydrochloride 55 mg modified-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012440","methylphenidate hydrochloride 70 mg modified-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012441","methylphenidate hydrochloride 85 mg modified-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012448","methylphenidate hydrochloride 100 mg modified-release oral capsule","NTP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012464","buprenorphine (buprenorphine hydrochloride) 150 mcg buccal film","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9012464","buprenorphine (buprenorphine hydrochloride) 150 mcg buccal film","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012465","buprenorphine (buprenorphine hydrochloride) 300 mcg buccal film","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9012465","buprenorphine (buprenorphine hydrochloride) 300 mcg buccal film","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012466","buprenorphine (buprenorphine hydrochloride) 450 mcg buccal film","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9012466","buprenorphine (buprenorphine hydrochloride) 450 mcg buccal film","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012467","buprenorphine (buprenorphine hydrochloride) 75 mcg buccal film","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9012467","buprenorphine (buprenorphine hydrochloride) 75 mcg buccal film","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012472","buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride) 3 mg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9012472","buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride) 3 mg sublingual tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012473","buprenorphine (buprenorphine hydrochloride) 16 mg and naloxone (naloxone hydrochloride) 4 mg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9012473","buprenorphine (buprenorphine hydrochloride) 16 mg and naloxone (naloxone hydrochloride) 4 mg sublingual tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012541","testosterone 1 % transdermal gel 2.5 g sachet","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012542","testosterone 1 % transdermal gel 5 g sachet","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012543","testosterone 1 % transdermal gel 5 g tube","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012592","testosterone 12.5 mg per actuation transdermal gel","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012593","testosterone 30 mg per actuation transdermal solution","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012635","hydromorphone hydrochloride 20 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9012635","hydromorphone hydrochloride 20 mg per mL solution for injection 50 mL vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012730","midazolam 10 mg per 10 mL solution for injection ampoule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012731","midazolam 10 mg per 10 mL solution for injection vial","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012732","midazolam 10 mg per 2 mL solution for injection ampoule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012733","midazolam 10 mg per 2 mL solution for injection vial","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012734","midazolam 15 mg per 3 mL solution for injection ampoule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012735","midazolam 2 mg per 2 mL solution for injection ampoule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012736","midazolam 2 mg per 2 mL solution for injection vial","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012737","midazolam 5 mg per 1 mL solution for injection ampoule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012738","midazolam 5 mg per 1 mL solution for injection vial","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012739","midazolam 5 mg per 5 mL solution for injection ampoule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012740","midazolam 5 mg per 5 mL solution for injection vial","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012741","midazolam 50 mg per 10 mL solution for injection ampoule","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012742","midazolam 50 mg per 10 mL solution for injection vial","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012743","nalbuphine hydrochloride 10 mg per 1 mL solution for injection ampoule","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012775","acetylsalicylic acid 375 mg and caffeine (caffeine citrate) 15 mg and codeine phosphate 30 mg oral tablet","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9012879","diazepam 10 mg per 2 mL solution for injection syringe","NTP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013352","sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013353","sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013354","sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013443","ketamine (ketamine hydrochloride) 100 mg per 2 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013444","ketamine (ketamine hydrochloride) 20 mg per 2 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013445","ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013446","ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013506","phenobarbital sodium 120 mg per 1 mL solution for injection ampoule","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013507","phenobarbital sodium 30 mg per 1 mL solution for injection ampoule","NTP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013658","buprenorphine hydrochloride 80 mg implant","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9013658","buprenorphine hydrochloride 80 mg implant","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013794","amphetamine mixed salts 10 mg prolonged-release oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013795","amphetamine mixed salts 15 mg prolonged-release oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013796","amphetamine mixed salts 20 mg prolonged-release oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013797","amphetamine mixed salts 25 mg prolonged-release oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013798","amphetamine mixed salts 30 mg prolonged-release oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9013799","amphetamine mixed salts 5 mg prolonged-release oral capsule","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9014113","lisdexamfetamine dimesylate 10 mg chewable tablet","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9014114","lisdexamfetamine dimesylate 20 mg chewable tablet","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9014115","lisdexamfetamine dimesylate 30 mg chewable tablet","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9014116","lisdexamfetamine dimesylate 40 mg chewable tablet","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9014117","lisdexamfetamine dimesylate 50 mg chewable tablet","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9014118","lisdexamfetamine dimesylate 60 mg chewable tablet","NTP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9014172","hydromorphone hydrochloride 20 mg per 50 mL solution for injection bag","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9014172","hydromorphone hydrochloride 20 mg per 50 mL solution for injection bag","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9014173","hydromorphone hydrochloride 40 mg per 100 mL solution for injection bag","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9014173","hydromorphone hydrochloride 40 mg per 100 mL solution for injection bag","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"9014225","morphine sulfate 10 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"9014225","morphine sulfate 10 mg per 1 mL solution for injection vial","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01913980","NUBAIN INJECTION 10MG/ML (nalbuphine hydrochloride 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02408007","FENTORA (fentanyl (fentanyl citrate) 100 mcg buccal tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02482681","MORPHINE SULFATE INJECTION, USP (morphine sulfate 2 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02320312","SANDOZ METHYLPHENIDATE SR (methylphenidate hydrochloride 20 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364190","ABSTRAL (fentanyl (fentanyl citrate) 300 mcg sublingual tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00725749","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 100 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02309882","PMS-OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02245758","PMS-OXYCODONE - ACETAMINOPHEN (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02448319","ACT DEXTROAMPHETAMINE SR (dextroamphetamine sulfate 10 mg prolonged-release oral capsule) TEVA CANADA LIMITED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02480859","MAR-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) MARCAN PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02125382","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG (hydromorphone hydrochloride 24 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02470292","FOQUEST (methylphenidate hydrochloride 25 mg modified-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247177","BIO-OXAZEPAM (oxazepam 10 mg oral tablet) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02465264","BELBUCA (buprenorphine (buprenorphine hydrochloride) 450 mcg buccal film) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01916386","PMS HYDROMORPHONE SIROP 1MG/ML (hydromorphone hydrochloride 1 mg per mL syrup) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02295709","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700302","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 (hydromorphone hydrochloride 10 mg per 1 mL solution for injection ampoule) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02372541","OXYNEO (oxycodone hydrochloride 30 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02482746","MORPHINE SULFATE INJECTION, USP (morphine sulfate 10 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02415607","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 200 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00414247","OXPAM (oxazepam 10 mg oral tablet) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02243240","DIAZEPAM AUTOINJECTOR (diazepam 10 mg per 2 mL solution for injection syringe) MERIDIAN MEDICAL TECHNOLOGIES INC.","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02245592","DAMYLIN WITH CODEINE SYRUP (ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02439255","ACT AMPHETAMINE XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) TEVA CANADA LIMITED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02337290","JURNISTA (hydromorphone hydrochloride 32 mg prolonged-release oral tablet) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02351099","LORAZEPAM (lorazepam 2 mg oral tablet) SANIS HEALTH INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02130998","DOM-CLONAZEPAM - TAB 0.5MG (clonazepam 0.5 mg oral tablet) DOMINION PHARMACAL","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02184435","KADIAN (morphine sulfate 20 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02247701","METADOL (methadone hydrochloride 25 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700346","MORPHINE HP 25 - 25MG/ML (morphine sulfate 25 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02453916","ACT BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02244791","SANDOZ MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02485532","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 20 mg per 50 mL solution for injection bag) STERINOVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02275848","DURAGESIC (fentanyl 75 mcg per hour transdermal patch) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02320428","M-EDIAT (morphine sulfate 10 mg oral capsule) ETHYPHARM INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394774","APO-OXYCODONE CR (oxycodone hydrochloride 30 mg prolonged-release oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02245972","ANDRODERM (testosterone 5 mg per 24 hour transdermal patch) ALLERGAN INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247698","METADOL (methadone hydrochloride 1 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00614505","DOLORAL 5 SIROP 5MG/ML (morphine hydrochloride 5 mg per mL syrup) LABORATOIRE ATLAS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02378299","NUCYNTA IR (tapentadol (tapentadol hydrochloride) 100 mg oral tablet) ENDO VENTURES LTD","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02286424","ZYTRAM XL (tramadol hydrochloride 150 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00728195","PMS-LORAZEPAM TAB 1MG (lorazepam 1 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364115","APO-HYDROMORPHONE (hydromorphone hydrochloride 1 mg oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00392480","SUPEUDOL 10 (oxycodone hydrochloride 10 mg suppository) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394219","ACT OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02366746","APO-OXYCODONE CR (oxycodone hydrochloride 5 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02230769","DALMACOL (alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrin hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup) LABORATOIRE RIVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00115630","LIBRAX (chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule) BAUSCH HEALTH, CANADA INC.","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247178","BIO-OXAZEPAM (oxazepam 15 mg oral tablet) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700349","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02396742","MYLAN-FENTANYL MATRIX PATCH (fentanyl 100 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02327147","SANDOZ FENTANYL PATCH (fentanyl 50 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247179","BIO-OXAZEPAM (oxazepam 30 mg oral tablet) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02401657","PMS-TRAMADOL-ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02125366","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG (hydromorphone hydrochloride 12 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02372525","OXYNEO (oxycodone hydrochloride 10 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02198630","CALMYLIN ACE (codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pheniramine maleate 7.5 mg per 5 mL syrup) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02341409","PMS-FENTANYL MTX (fentanyl 75 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02358077","RAN-NABILONE (nabilone 0.25 mg oral capsule) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02019957","M-ESLON (morphine sulfate 60 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02177749","M-ESLON (morphine sulfate 15 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02169126","TEVA-COTRIDIN (codeine phosphate 10 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02470306","FOQUEST (methylphenidate hydrochloride 35 mg modified-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02439298","ACT AMPHETAMINE XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) TEVA CANADA LIMITED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02330113","RAN-FENTANYL MATRIX PATCH (fentanyl 25 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02366789","APO-OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700608","MIDAZOLAM INJECTION (midazolam 50 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02230950","MYLAN-CLONAZEPAM (clonazepam 0.5 mg oral tablet) MYLAN PHARMACEUTICALS ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02242163","KADIAN (morphine sulfate 10 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02440407","PMS-AMPHETAMINES XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) PHARMASCIENCE INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02270668","CO CLONAZEPAM (clonazepam 1 mg oral tablet) COBALT PHARMACEUTICALS COMPANY","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247492","PMS-DIAZEPAM (diazepam 10 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02019949","M-ESLON (morphine sulfate 30 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02465248","BELBUCA (buprenorphine (buprenorphine hydrochloride) 150 mcg buccal film) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00005614","RITALIN 20MG (methylphenidate hydrochloride 20 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01949055","MORPHINE-EPD (morphine sulfate 5 mg per 5 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700520","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02394197","ACT OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02341417","PMS-FENTANYL MTX (fentanyl 100 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364131","APO-HYDROMORPHONE (hydromorphone hydrochloride 4 mg oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394170","ACT OXYCODONE CR (oxycodone hydrochloride 5 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476665","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 18 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02184443","KADIAN (morphine sulfate 50 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00402745","APO OXAZEPAM TAB 15MG (oxazepam 15 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02277212","BIPHENTIN (methylphenidate hydrochloride 80 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00711101","TEVA-LORAZEPAM (lorazepam 0.5 mg oral tablet) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01913492","TEVA-ALPRAZOLAM (alprazolam 0.5 mg oral tablet) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02485540","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 40 mg per 100 mL solution for injection bag) STERINOVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02047667","MERSYNDOL WITH CODEINE (acetaminophen 325 mg and codeine phosphate 8 mg and doxylamine succinate 5 mg oral tablet) SANOFI-AVENTIS CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02234007","SANDOZ NITRAZEPAM (nitrazepam 10 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02324628","APO-OXYCODONE/ACET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02396734","MYLAN-FENTANYL MATRIX PATCH (fentanyl 75 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700450","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00224405","KETALAR (ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial) ERFA CANADA 2012 INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00594636","STATEX TABLET 25MG (morphine sulfate 25 mg oral tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02341174","BUTRANS 5 (buprenorphine 5 mcg per hour transdermal patch) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700489","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) TELIGENT OU","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00860697","CLORAZEPATE (clorazepate dipotassium 15 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02415577","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 50 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247700","METADOL (methadone hydrochloride 10 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02347180","TEVA-TRAMADOL/ACETAMINOPHEN (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00860700","CLORAZEPATE (clorazepate dipotassium 7.5 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700600","MIDAZOLAM INJECTION (midazolam 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02490226","VYVANSE (lisdexamfetamine dimesylate 10 mg chewable tablet) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02041464","ATIVAN (lorazepam 1 mg sublingual tablet) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00618454","CHLORAX (chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02177757","M-ESLON (morphine sulfate 200 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00640409","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 10 mg per mL solution for injection 30 mL vial) ICU MEDICAL CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02364158","APO-HYDROMORPHONE (hydromorphone hydrochloride 8 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00655651","PRO-LORAZEPAM TAB 1.0MG (lorazepam 1 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01971409","TRIANAL TABLET (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet) LABORATOIRE RIVA INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02224100","DOM-CLONAZEPAM-R - TAB 0.5MG (clonazepam 0.5 mg oral tablet) DOMINION PHARMACAL","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02296381","TRIDURAL (tramadol hydrochloride 100 mg prolonged-release oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02286440","ZYTRAM XL (tramadol hydrochloride 300 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02364182","ABSTRAL (fentanyl (fentanyl citrate) 200 mcg sublingual tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700304","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02349469","ULTRAM (tramadol hydrochloride 50 mg oral tablet) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02350912","MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) SANIS HEALTH INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02282984","TEVA-FENTANYL (fentanyl 100 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02395665","FENTANYL PATCH (fentanyl 25 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02334186","DURAGESIC (fentanyl 12 mcg per hour transdermal patch) JANSSEN INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700341","MORPHINE EXTRA-FORTE (morphine sulfate 50 mg per mL solution for injection 20 mL vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02327139","SANDOZ FENTANYL PATCH (fentanyl 37 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700305","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00726389","PMS-OXAZEPAM TAB 30MG (oxazepam 30 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014327","MS CONTIN SRT 200MG (morphine sulfate 200 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02019965","M-ESLON (morphine sulfate 100 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00293490","ATASOL 8 (acetaminophen 325 mg and caffeine citrate 30 mg and codeine phosphate 8 mg oral tablet) CHURCH & DWIGHT CANADA CORP","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02248126","BIO-FLURAZEPAM (flurazepam hydrochloride 15 mg oral capsule) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00405329","DIAZEPAM (diazepam 2 mg oral tablet) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02415585","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 100 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02296403","TRIDURAL (tramadol hydrochloride 200 mg prolonged-release oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02350815","MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) SANIS HEALTH INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00443948","SUPEUDOL 10 (oxycodone hydrochloride 10 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02463806","TARO-TESTOSTERONE GEL 5G/PACKET (testosterone 1 % transdermal gel 5 g sachet) TARO PHARMACEUTICALS INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02239024","TEVA-CLONAZEPAM (clonazepam 0.5 mg oral tablet) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02415615","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 250 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02395703","FENTANYL PATCH (fentanyl 100 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00655740","APO-LORAZEPAM TAB 0.5MG (lorazepam 0.5 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00850330","MORPHINE SULFATE INJECTION USP (morphine sulfate 15 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02423758","MIDAZOLAM INJECTION (midazolam 5 mg per 5 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02320398","M-EDIAT (morphine sulfate 5 mg oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00789739","SUPEUDOL 5 (oxycodone hydrochloride 5 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02009889","CODEINE 15 (codeine phosphate 15 mg oral tablet) LABORATOIRE RIVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02248810","ADDERALL XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02490277","VYVANSE (lisdexamfetamine dimesylate 60 mg chewable tablet) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700619","MIDAZOLAM INJECTION SDZ (midazolam 10 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02458071","VYVANSE (lisdexamfetamine dimesylate 70 mg oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02384884","TEVA-NABILONE (nabilone 0.5 mg oral capsule) TEVA CANADA LIMITED","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00636908","MORPHINE SULFATE INJECTION USP (morphine sulfate 30 mg per 30 mL solution for injection vial) ICU MEDICAL CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700343","MORPHINE FORTE (morphine sulfate 100 mg per 4 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02424878","PMS-BUPRENORPHINE-NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00608165","TEVA-OXYCOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00594652","STATEX TAB 5MG (morphine sulfate 5 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02302780","TEVA-MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00885444","PMS-HYDROMORPHONE TAB 1MG (hydromorphone hydrochloride 1 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02476673","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 24 mg prolonged-release oral capsule) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700517","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01916580","HYCODAN SYRUP (hydrocodone bitartrate 5 mg per 5 mL syrup) BRISTOL-MYERS SQUIBB CANADA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00607762","RATIO-MORPHINE (morphine hydrochloride 1 mg per mL syrup) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00568392","RIVA OXAZEPAM (oxazepam 10 mg oral tablet) LABORATOIRE RIVA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02233985","SANDOZ CLONAZEPAM (clonazepam 2 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02382369","AXIRON (testosterone 30 mg per actuation transdermal solution) ELI LILLY CANADA INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476649","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 9 mg prolonged-release oral capsule) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700449","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02145901","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00030783","DEPO-TESTOSTERONE INJ 100MG/ML (testosterone cypionate 1000 mg per 10 mL solution for injection vial) PFIZER CANADA ULC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02386879","CO FENTANYL (fentanyl 50 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00125121","DILAUDID (hydromorphone hydrochloride 4 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00125083","DILAUDID (hydromorphone hydrochloride 2 mg oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700613","MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 5 mg per 1 mL solution for injection vial) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700347","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02245345","ANDROGEL (testosterone 1 % transdermal gel 2.5 g sachet) BGP PHARMA ULC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02242005","DEMEROL 100 MG/ML (meperidine hydrochloride 100 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02325969","OXYCODONE (oxycodone hydrochloride 10 mg oral tablet) PRO DOC LIMITEE","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02442043","CLONAZEPAM (clonazepam 1 mg oral tablet) SIVEM PHARMACEUTICALS ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02230302","CODEINE CONTIN 50MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 50 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394618","METHADOSE DYE FREE, SUGAR FREE, UNFLAVORED (methadone hydrochloride 10 mg per mL oral solution) MALLINCKRODT CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02325950","OXYCODONE (oxycodone hydrochloride 5 mg oral tablet) PRO DOC LIMITEE","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394200","ACT OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02438704","LORAZEPAM INJECTION USP (lorazepam 2 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00726370","PMS-OXAZEPAM TAB 15MG (oxazepam 15 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00607770","RATIO-MORPHINE (morphine hydrochloride 5 mg per mL syrup) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01916963","TUSSIONEX (hydrocodone 5 mg and phenyltoloxamine 10 mg prolonged-release oral tablet) SANOFI-AVENTIS CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00789828","TRIATEC-30 (acetaminophen 300 mg and codeine phosphate 30 mg oral tablet) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00362158","DIAZEPAM (diazepam 5 mg oral tablet) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00568414","RIVA OXAZEPAM (oxazepam 30 mg oral tablet) LABORATOIRE RIVA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02339625","TARGIN (naloxone hydrochloride 20 mg and oxycodone hydrochloride 40 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01916599","HYCODAN TABLETS (hydrocodone bitartrate 5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02250241","CONCERTA (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) JANSSEN INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00392588","MORPHINE SULFATE INJ 10MG/ML USP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02048728","PMS-CLONAZEPAM TAB 1.0MG (clonazepam 1 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476657","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 12 mg prolonged-release oral capsule) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02282968","TEVA-FENTANYL (fentanyl 50 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00891797","PMS-DIAZEPAM SOLUTION 1MG/ML (diazepam 1 mg per mL oral solution) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00382841","RIVOTRIL 2TAB (clonazepam 2 mg oral tablet) HOFFMANN-LA ROCHE LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02408058","FENTORA (fentanyl (fentanyl citrate) 800 mcg buccal tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02014300","MS CONTIN SRT 60MG (morphine sulfate 60 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00392472","SUPEUDOL 20 (oxycodone hydrochloride 20 mg suppository) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02229761","TEMAZEPAM-30 (temazepam 30 mg oral capsule) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00614491","DOLORAL 1 (morphine hydrochloride 1 mg per mL syrup) LABORATOIRE ATLAS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02242468","RIVACOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02448327","ACT DEXTROAMPHETAMINE SR (dextroamphetamine sulfate 15 mg prolonged-release oral capsule) TEVA CANADA LIMITED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02424851","PMS-BUPRENORPHINE-NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00608211","TEVA-TECNAL (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet) TEVA CANADA LIMITED","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02319438","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 4 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00414239","SOM-PAM (flurazepam hydrochloride 30 mg oral capsule) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700303","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02299208","RALIVIA (tramadol hydrochloride 200 mg prolonged-release oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02322978","VYVANSE (lisdexamfetamine dimesylate 50 mg oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02445492","APO-AMPHETAMINE XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) APOTEX INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01977881","TRIATEC-8 FORT (acetaminophen 500 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700447","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02025337","ACETAMINOPHEN, CAFFEINE & CODEINE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02314665","APO-FENTANYL MATRIX (fentanyl 100 mcg per hour transdermal patch) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01908189","ALPRAZOLAM-0.25 (alprazolam 0.25 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244790","SANDOZ MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02396718","MYLAN-FENTANYL MATRIX PATCH (fentanyl 25 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02243562","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG (hydromorphone hydrochloride 18 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02247374","METADOL-D (methadone hydrochloride 1 mg per mL oral solution) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00786543","DILAUDID (hydromorphone hydrochloride 8 mg oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02319446","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 8 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02372576","OXYNEO (oxycodone hydrochloride 60 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02041413","ATIVAN (lorazepam 0.5 mg oral tablet) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02408104","MYLAN-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01924516","DEXEDRINE TABLETS (5MG) (dextroamphetamine sulfate 5 mg oral tablet) PALADIN LABS INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02465221","BELBUCA (buprenorphine (buprenorphine hydrochloride) 75 mcg buccal film) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02224577","COPHYLAC (normethadone hydrochloride 10 mg per mL and p-hydroxyephedrine hydrochloride 20 mg per mL oral drops) BAUSCH HEALTH, CANADA INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02326248","METHYLPHENIDATE (methylphenidate hydrochloride 10 mg oral tablet) PRO DOC LIMITEE","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00705438","DILAUDID (hydromorphone hydrochloride 1 mg oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014297","MS CONTIN SRT 30MG (morphine sulfate 30 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700291","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02408090","MYLAN-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02339609","TARGIN (naloxone hydrochloride 5 mg and oxycodone hydrochloride 10 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02359502","HYDROMORPH CONTIN (hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00544884","CODEINE PHOSPHATE INJECTION USP (codeine phosphate 30 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02177889","APO-CLONAZEPAM - TAB 0.5MG (clonazepam 0.5 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02341387","PMS-FENTANYL MTX (fentanyl 25 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02440385","PMS-AMPHETAMINES XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) PHARMASCIENCE INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02309890","PMS-OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02021048","MORPHINE LP EPIDURAL (morphine sulfate 5 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02249324","APO-METHYLPHENIDATE (methylphenidate hydrochloride 10 mg oral tablet) APOTEX INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700353","MORPHINE SULFATE INJ 1MG/ML USP (morphine sulfate 5 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02302772","TEVA-MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394189","ACT OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02440369","PMS-AMPHETAMINES XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) PHARMASCIENCE INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00178829","PHENOBARB (phenobarbital 100 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01916491","PERCOCET-DEMI (acetaminophen 325 mg and oxycodone hydrochloride 2.5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700358","MORPHINE SULPHATE INJECTION 1MG/ML (morphine sulfate 1 mg per mL solution for injection 50 mL vial) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02009757","CODEINE 30 (codeine phosphate 30 mg oral tablet) LABORATOIRE RIVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02366754","APO-OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02445522","APO-AMPHETAMINE XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) APOTEX INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700070","DIASTAT (diazepam 15 mg per 3 mL rectal gel tube) VALEANT PHARMACEUTICALS NORTH AMERICA LLC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02337282","JURNISTA (hydromorphone hydrochloride 16 mg prolonged-release oral tablet) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02327155","SANDOZ FENTANYL PATCH (fentanyl 75 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02248817","ACETAMINOPHEN, CAFFEINE AND 8 MG OF CODEINE PHOSPHATE TABLETS (acetaminophen 325 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) CELLCHEM PHARMACEUTICALS INC.","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02468468","HYDROMORPHONE HYDROCHLORIDE INJECTION HP FORTE (hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02396696","MYLAN-FENTANYL MATRIX PATCH (fentanyl 12 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00608238","TEVA-TECNAL (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule) TEVA CANADA LIMITED","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02426153","APO-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02490242","VYVANSE (lisdexamfetamine dimesylate 30 mg chewable tablet) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364204","ABSTRAL (fentanyl (fentanyl citrate) 400 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02395681","FENTANYL PATCH (fentanyl 75 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02481979","SANDOZ METHADONE (methadone hydrochloride 10 mg per mL oral solution) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02015439","MS CONTIN SRT 15MG (morphine sulfate 15 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02240131","OXY.IR (oxycodone hydrochloride 10 mg oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247699","METADOL (methadone hydrochloride 5 mg oral tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00850322","MORPHINE SULFATE INJECTION USP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02404893","RIVA-ALPRAZOLAM (alprazolam 1 mg oral tablet) LABORATOIRE RIVA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476622","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700298","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02450429","TARO-TRAMADOL ER (tramadol hydrochloride 100 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02230585","TEVA-BROMAZEPAM (bromazepam 6 mg oral tablet) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02314630","APO-FENTANYL MATRIX (fentanyl 25 mcg per hour transdermal patch) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02330156","RAN-FENTANYL MATRIX PATCH (fentanyl 100 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244508","PMS-BUTORPHANOL (butorphanol tartrate 10 mg per mL nasal spray) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00013285","VALIUM 5 TAB (diazepam 5 mg oral tablet) HOFFMANN-LA ROCHE LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02327171","OXYCODONE-ACET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02426803","TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) SANIS HEALTH INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01996568","ACETAMINOPHENE CODEINE ET CAFEINE FORT (acetaminophen 500 mg and caffeine citrate 30 mg and codeine phosphate 8 mg oral tablet) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02457296","SANDOZ AMPHETAMINE XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014211","MS.IR (morphine sulfate 10 mg oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02341379","PMS-FENTANYL MTX (fentanyl 12 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02483084","SUBLOCADE (buprenorphine 100 mg per 0.5 mL prolonged-release solution for injection syringe) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00865400","APO-ALPRAZ (alprazolam 0.5 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02049473","NOVAHISTINE DH (hydrocodone bitartrate 1.7 mg per 5 mL and phenylephrine hydrochloride 10 mg per 5 mL syrup) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02048701","PMS-CLONAZEPAM TAB 0.5MG (clonazepam 0.5 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700351","MORPHINE SULFATE INJ 1MG/ML USP (morphine sulfate 10 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02410745","LORAZEPAM SUBLINGUAL (lorazepam 0.5 mg sublingual tablet) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02372533","OXYNEO (oxycodone hydrochloride 15 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02408031","FENTORA (fentanyl (fentanyl citrate) 600 mcg buccal tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02490234","VYVANSE (lisdexamfetamine dimesylate 20 mg chewable tablet) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00497282","CODEINE PHOSPHATE INJ 30MG/ML (codeine phosphate 30 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02275856","DURAGESIC (fentanyl 100 mcg per hour transdermal patch) JANSSEN INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02490250","VYVANSE (lisdexamfetamine dimesylate 40 mg chewable tablet) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02344424","REMIFENTANIL FOR INJECTION (remifentanil (remifentanil hydrochloride) 1 mg per vial powder for solution for injection) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02441942","ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) ACTAVIS PHARMA COMPANY","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02327112","SANDOZ FENTANYL PATCH (fentanyl 12 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02319993","PMS-OXYCODONE (oxycodone hydrochloride 20 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02457326","SANDOZ AMPHETAMINE XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02243978","PMS-CODEINE (codeine phosphate 15 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00050024","CODEINE PHOSPHATE SYRUP (codeine phosphate 25 mg per 5 mL syrup) LABORATOIRE ATLAS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700296","HYDROMORPHONE HP 20 (hydromorphone hydrochloride 20 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364220","ABSTRAL (fentanyl (fentanyl citrate) 800 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02450550","NATESTO (testosterone 4.5 % nasal gel) ACERUS BIOPHARMA INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00690791","RATIO-MORPHINE (morphine hydrochloride 20 mg per mL syrup) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700623","MIDAZOLAM INJECTION (midazolam 5 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02177897","APO-CLONAZEPAM - TAB 2MG (clonazepam 2 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02380900","PMS-NABILONE (nabilone 0.5 mg oral capsule) PHARMASCIENCE INC","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700516","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00632228","STATEX SUPPOSITORIES 5MG (morphine sulfate 5 mg suppository) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02241377","METADOL (methadone hydrochloride 10 mg per mL oral solution) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02247490","PMS-DIAZEPAM (diazepam 2 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700624","MIDAZOLAM INJECTION (midazolam 50 mg per 10 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247733","CONCERTA (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) JANSSEN INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02330121","RAN-FENTANYL MATRIX PATCH (fentanyl 50 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02238334","TEVA-CLOBAZAM (clobazam 10 mg oral tablet) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02231934","OXY.IR (oxycodone hydrochloride 5 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02386852","CO FENTANYL (fentanyl 25 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02137240","MORPHINE SULPHATE INJECTION 2MG/ML (morphine sulfate 2 mg per mL solution for injection 50 mL vial) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02264846","TRAMACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02247694","METADOL (methadone hydrochloride 1 mg per mL oral solution) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02312263","CESAMET (nabilone 0.25 mg oral capsule) BAUSCH HEALTH, CANADA INC.","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244079","DIMETANE EXPECTORANT C (brompheniramine maleate 2 mg per 5 mL and codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01964429","MORPHINE SULFATE INJ 5MG/ML USP (morphine sulfate 5 mg per mL solution for injection 30 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700294","HYDROMORPHONE HP 20 (hydromorphone hydrochloride 20 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02408015","FENTORA (fentanyl (fentanyl citrate) 200 mcg buccal tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02302799","TEVA-MORPHINE SR (morphine sulfate 100 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00604461","RESTORIL (temazepam 30 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244792","SANDOZ MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700299","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02277166","BIPHENTIN (methylphenidate hydrochloride 10 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02021056","MORPHINE LP EPIDURAL (morphine sulfate 5 mg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700290","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 100 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02282976","TEVA-FENTANYL (fentanyl 75 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02137984","TALWIN (pentazocine (pentazocine hydrochloride) 50 mg oral tablet) SANOFI-AVENTIS CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02245786","DOM-LORAZEPAM (lorazepam 2 mg oral tablet) DOMINION PHARMACAL","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02339617","TARGIN (naloxone hydrochloride 10 mg and oxycodone hydrochloride 20 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02474921","PROBUPHINE (buprenorphine hydrochloride 80 mg implant) KNIGHT THERAPEUTICS INC.","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00621935","STATEX DROPS 20MG/ML (morphine sulfate 20 mg per mL oral drops) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02378280","NUCYNTA IR (tapentadol (tapentadol hydrochloride) 75 mg oral tablet) ENDO VENTURES LTD","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02372797","OXYNEO (oxycodone hydrochloride 20 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00728187","PMS-LORAZEPAM TAB 0.5MG (lorazepam 0.5 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02361361","OXYCODONE/ACET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) SANIS HEALTH INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01934767","ROBAXACET-8 (acetaminophen 325 mg and codeine phosphate 8 mg and methocarbamol 400 mg oral tablet) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02322498","PMS-TESTOSTERONE (testosterone undecanoate 40 mg oral capsule) PHARMASCIENCE INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700340","MORPHINE EXTRA-FORTE (morphine sulfate 50 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01924559","DEXEDRINE SPANSULE SRC 10MG (dextroamphetamine sulfate 10 mg prolonged-release oral capsule) PALADIN LABS INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00224391","KETALAR (ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial) ERFA CANADA 2012 INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476614","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 3 mg prolonged-release oral capsule) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00653276","TEVA-LENOLTEC NO. 3 (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 30 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02314649","APO-FENTANYL MATRIX (fentanyl 50 mcg per hour transdermal patch) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00885428","PMS-HYDROMORPHONE TAB 8MG (hydromorphone hydrochloride 8 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02295695","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02337274","JURNISTA (hydromorphone hydrochloride 8 mg prolonged-release oral tablet) JANSSEN INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02396726","MYLAN-FENTANYL MATRIX PATCH (fentanyl 50 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700932","KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02262983","SUPEUDOL (oxycodone hydrochloride 20 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02244290","METADOL-D (methadone hydrochloride 10 mg per mL oral solution) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247176","BIO-DIAZEPAM (diazepam 10 mg oral tablet) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02382377","MIDAZOLAM INJECTION USP WITH PRESERVATIVE (midazolam 10 mg per 10 mL solution for injection vial) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02470349","FOQUEST (methylphenidate hydrochloride 85 mg modified-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02053403","TEVA-COTRIDIN EXPECTORANT (codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02225964","TEMAZEPAM (temazepam 15 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02163799","CODEINE CONTIN 200MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 200 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02320436","M-EDIAT (morphine sulfate 20 mg oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02242006","DEMEROL 100 MG/ML (meperidine hydrochloride 100 mg per mL solution for injection 20 mL vial) HOSPIRA HEALTHCARE ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02372568","OXYNEO (oxycodone hydrochloride 40 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476681","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 30 mg prolonged-release oral capsule) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02327120","SANDOZ FENTANYL PATCH (fentanyl 25 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02330377","APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) APOTEX INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02385392","DIAZEPAM INJECTION USP (diazepam 10 mg per 2 mL solution for injection ampoule) TELIGENT OU","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01908170","ALPRAZOLAM-0.5 (alprazolam 0.5 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02386844","CO FENTANYL (fentanyl 12 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02341220","BUTRANS 20 (buprenorphine 20 mcg per hour transdermal patch) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02163748","CODEINE CONTIN 100MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 100 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700957","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 (hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial) STERIMAX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02125390","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG (hydromorphone hydrochloride 30 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02453908","ACT BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02373025","DURELA (tramadol hydrochloride 200 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02028174","ACETAMINOPHEN, CAFFEINE & CODEINE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02309912","PMS-OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02242484","MORPHINE SULFATE INJECTION USP (morphine sulfate 2 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02415593","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 150 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00637750","TEVA-LORAZEPAM (lorazepam 2 mg oral tablet) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02326221","METHYLPHENIDATE (methylphenidate hydrochloride 5 mg oral tablet) PRO DOC LIMITEE","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247491","PMS-DIAZEPAM (diazepam 5 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02387425","TARGIN (naloxone hydrochloride 2.5 mg and oxycodone hydrochloride 5 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00594644","STATEX TAB 10MG (morphine sulfate 10 mg oral tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01966375","METHOXISAL-C 1/2 (acetylsalicylic acid 325 mg and codeine phosphate 32.4 mg and methocarbamol 400 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02302764","TEVA-MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02366762","APO-OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02413744","PMS-METHYLPHENIDATE ER (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02309904","PMS-OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02436159","APO-ZOLPIDEM ODT (zolpidem tartrate 5 mg orodispersible tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02240132","OXY.IR (oxycodone hydrochloride 20 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02359510","HYDROMORPH CONTIN (hydromorphone hydrochloride 9 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00399728","DIAZEPAM INJECTION USP (diazepam 10 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394782","APO-OXYCODONE CR (oxycodone hydrochloride 60 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700356","MORPHINE SULFATE INJECTION SDZ (morphine sulfate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00497290","CODEINE PHOSPHATE INJ 60MG/ML (codeine phosphate 60 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00608203","TEVA-TECNAL C 1/4 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02391678","SUBLINOX (zolpidem tartrate 5 mg orodispersible tablet) BAUSCH HEALTH, CANADA INC.","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02229813","MYLAN-ALPRAZOLAM (alprazolam 1 mg oral tablet) MYLAN PHARMACEUTICALS ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02230951","MYLAN-CLONAZEPAM (clonazepam 2 mg oral tablet) MYLAN PHARMACEUTICALS ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02242003","DEMEROL 50 MG/ML   (SINGLE USE, PRESERVATIVE FREE) (meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02445549","APO-AMPHETAMINE XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) APOTEX INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02286432","ZYTRAM XL (tramadol hydrochloride 200 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700615","MIDAZOLAM INJECTION SDZ (midazolam 10 mg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02474980","MORPHINE SULFATE INJECTION BP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02450771","BUTRANS 15 (buprenorphine 15 mcg per hour transdermal patch) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02468085","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride dihydrate) 3 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00005606","RITALIN 10MG (methylphenidate hydrochloride 10 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02319411","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 2 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02302802","TEVA-MORPHINE SR (morphine sulfate 200 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700357","MORPHINE SULFATE INJECTION SDZ (morphine sulfate 50 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364212","ABSTRAL (fentanyl (fentanyl citrate) 600 mcg sublingual tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700292","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02041448","ATIVAN (lorazepam 2 mg oral tablet) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244078","DIMETAPP-C (brompheniramine maleate 2 mg per 5 mL and codeine phosphate 10 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02306530","APO-OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02314657","APO-FENTANYL MATRIX (fentanyl 75 mcg per hour transdermal patch) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02351080","LORAZEPAM (lorazepam 1 mg oral tablet) SANIS HEALTH INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02249499","ANDROGEL (testosterone 12.5 mg per actuation transdermal gel) BGP PHARMA ULC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02325977","OXYCODONE (oxycodone hydrochloride 20 mg oral tablet) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02330148","RAN-FENTANYL MATRIX PATCH (fentanyl 75 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02324253","PDP-HYDROCODONE (hydrocodone bitartrate 5 mg per 5 mL syrup) PENDOPHARM DIVISION OF PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02364174","ABSTRAL (fentanyl (fentanyl citrate) 100 mcg sublingual tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00675962","STATEX TABLETS 50MG (morphine sulfate 50 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00690783","RATIO-MORPHINE (morphine hydrochloride 10 mg per mL syrup) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02465256","BELBUCA (buprenorphine (buprenorphine hydrochloride) 300 mcg buccal film) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700488","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) TELIGENT OU","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700451","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 2500 mcg per 50 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02014203","MS.IR (morphine sulfate 5 mg oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02378272","NUCYNTA IR (tapentadol (tapentadol hydrochloride) 50 mg oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01916971","TUSSIONEX (hydrocodone 5 mg per 5 mL and phenyltoloxamine 10 mg per 5 mL oral suspension) SANOFI-AVENTIS CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014254","MS.IR (morphine sulfate 30 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02299216","RALIVIA (tramadol hydrochloride 300 mg prolonged-release oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02400146","JAMP-ALPRAZOLAM (alprazolam 1 mg oral tablet) JAMP PHARMA CORPORATION","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02478889","SANDOZ MORPHINE SR (morphine sulfate 100 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02380919","PMS-NABILONE (nabilone 1 mg oral capsule) PHARMASCIENCE INC","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02413728","PMS-METHYLPHENIDATE ER (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02243979","PMS-CODEINE (codeine phosphate 30 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00593451","TEVA-CODEINE (codeine phosphate 30 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00639389","STATEX SUPPOSITORIES 30MG (morphine sulfate 30 mg suppository) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02311925","TEVA-FENTANYL (fentanyl 12 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02358093","RAN-NABILONE (nabilone 1 mg oral capsule) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02386887","CO FENTANYL (fentanyl 75 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02440415","PMS-AMPHETAMINES XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) PHARMASCIENCE INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00521701","FLURAZEPAM (flurazepam hydrochloride 30 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700519","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02460602","HYDROMORPHONE HYDROCHLORIDE INJECTION (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700606","MIDAZOLAM INJECTION (midazolam 5 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00578487","FLURAZEPAM 30 (flurazepam hydrochloride 30 mg oral capsule) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02311593","PRO-CLONAZEPAM (clonazepam 0.5 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00176206","FIORINAL-C 1/2 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule) ARALEZ PHARMACEUTICALS CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00382825","RIVOTRIL 0.5TAB (clonazepam 0.5 mg oral tablet) HOFFMANN-LA ROCHE LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02230584","TEVA-BROMAZEPAM (bromazepam 3 mg oral tablet) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02452731","APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) APOTEX INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00706221","ACETAMINOPHEN 325 MG WITH 15 MG CAFFEINE AND 8 MG CODEINE PHOSPHATE (acetaminophen 325 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) VITA HEALTH PRODUCTS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244474","PMS-CLOBAZAM (clobazam 10 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00548375","CESAMET (nabilone 1 mg oral capsule) BAUSCH HEALTH, CANADA INC.","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02220539","BROMAZEPAM-6 - TAB 6MG (bromazepam 6 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00649619","MORPHINE SULFATE INJECTION USP (morphine sulfate 150 mg per 30 mL solution for injection vial) ICU MEDICAL CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700929","KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 20 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00392561","MORPHINE SULFATE INJ 15MG/ML USP (morphine sulfate 15 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700486","FENTANYL CITRATE INJECTION SDZ (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700604","MIDAZOLAM INJECTION (midazolam 2 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394766","APO-OXYCODONE CR (oxycodone hydrochloride 15 mg prolonged-release oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02441934","ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) ACTAVIS PHARMA COMPANY","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02184451","KADIAN (morphine sulfate 100 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02229760","TEMAZEPAM-15 (temazepam 15 mg oral capsule) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00596965","STATEX SUPPOSITORIES 20MG (morphine sulfate 20 mg suppository) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00608157","TEVA-OXYCODAN (acetylsalicylic acid 325 mg and oxycodone hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02341212","BUTRANS 10 (buprenorphine 10 mcg per hour transdermal patch) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00725765","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700612","MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 2 mg per 2 mL solution for injection vial) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00816027","PMS-ACETAMINOPHEN WITH CODEINE ELIXIR (acetaminophen 160 mg per 5 mL and codeine phosphate 8 mg per 5 mL oral solution) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02315084","TEVA-METHYLPHENIDATE ER-C (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02347156","VYVANSE (lisdexamfetamine dimesylate 20 mg oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02395673","FENTANYL PATCH (fentanyl 50 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700352","MORPHINE SULFATE INJ 1MG/ML USP (morphine sulfate 1 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700342","MORPHINE EXTRA-FORTE (morphine sulfate 50 mg per mL solution for injection 50 mL vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02041456","ATIVAN (lorazepam 0.5 mg sublingual tablet) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00497754","OXAZEPAM 10 TAB 10MG (oxazepam 10 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02457334","SANDOZ AMPHETAMINE XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02270641","CO CLONAZEPAM (clonazepam 0.5 mg oral tablet) COBALT PHARMACEUTICALS COMPANY","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364123","APO-HYDROMORPHONE (hydromorphone hydrochloride 2 mg oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02275813","DURAGESIC (fentanyl 25 mcg per hour transdermal patch) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00653241","TEVA-LENOLTEC NO. 2 (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 15 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700300","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700518","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02439247","ACT AMPHETAMINE XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) TEVA CANADA LIMITED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02282941","TEVA-FENTANYL (fentanyl 25 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700902","SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection ampoule) STERIMAX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02478897","SANDOZ MORPHINE SR (morphine sulfate 200 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700293","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02275821","DURAGESIC (fentanyl 50 mcg per hour transdermal patch) JANSSEN INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00507407","DALMACOL (alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrin hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup) LABORATOIRE ATLAS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244638","APO-CLOBAZAM (clobazam 10 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00380571","LINCTUS CODEINE BLANC (codeine phosphate 10 mg per 5 mL oral solution) LABORATOIRE ATLAS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02350890","MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) SANIS HEALTH INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02019930","M-ESLON (morphine sulfate 10 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02358085","RAN-NABILONE (nabilone 0.5 mg oral capsule) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02242004","DEMEROL 75 MG/ML (meperidine hydrochloride 75 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00604453","RESTORIL (temazepam 15 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02319977","PMS-OXYCODONE (oxycodone hydrochloride 5 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700344","MORPHINE FORTE (morphine sulfate 25 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02372541","OXYNEO (oxycodone hydrochloride 30 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02415607","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 200 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00885436","PMS-HYDROMORPHONE TAB 2MG (hydromorphone hydrochloride 2 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02482746","MORPHINE SULFATE INJECTION, USP (morphine sulfate 10 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00511536","MOGADON (nitrazepam 10 mg oral tablet) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02184435","KADIAN (morphine sulfate 20 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02241976","TALWIN (pentazocine (pentazocine lactate) 30 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247364","RATIO-METHYLPHENIDATE (methylphenidate hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247734","CONCERTA (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) JANSSEN INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00497762","OXAZEPAM 15 TAB 15MG (oxazepam 15 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02242406","TRIANAL C (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00728209","PMS-LORAZEPAM TAB 2MG (lorazepam 2 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02125323","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG (hydromorphone hydrochloride 3 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02337290","JURNISTA (hydromorphone hydrochloride 32 mg prolonged-release oral tablet) JANSSEN INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02242180","MUSCLE & BACK PAIN RELIEF - 8 (acetaminophen 325 mg and codeine phosphate 8 mg and methocarbamol 400 mg oral tablet) VITA HEALTH PRODUCTS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02125331","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG (hydromorphone hydrochloride 6 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02483092","SUBLOCADE (buprenorphine 300 mg per 1.5 mL prolonged-release solution for injection syringe) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02320444","M-EDIAT (morphine sulfate 30 mg oral capsule) ETHYPHARM INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247701","METADOL (methadone hydrochloride 25 mg oral tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02154234","ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700359","MORPHINE SULPHATE INJECTION 1MG/ML (morphine sulfate 5 mg per 5 mL solution for injection vial) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02247698","METADOL (methadone hydrochloride 1 mg oral tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00614505","DOLORAL 5 SIROP 5MG/ML (morphine hydrochloride 5 mg per mL syrup) LABORATOIRE ATLAS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02249332","APO-METHYLPHENIDATE (methylphenidate hydrochloride 20 mg oral tablet) APOTEX INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02243278","LORAZEPAM INJECTION USP (lorazepam 4 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02275848","DURAGESIC (fentanyl 75 mcg per hour transdermal patch) JANSSEN INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02485532","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 20 mg per 50 mL solution for injection bag) STERINOVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244791","SANDOZ MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700346","MORPHINE HP 25 - 25MG/ML (morphine sulfate 25 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02453916","ACT BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700355","MORPHINE SULFATE INJ 2MG/ML USP (morphine sulfate 2 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02307898","SANDOZ OXYCODONE/ACETAMINOPHEN (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02327163","SANDOZ FENTANYL PATCH (fentanyl 100 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394774","APO-OXYCODONE CR (oxycodone hydrochloride 30 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02320428","M-EDIAT (morphine sulfate 10 mg oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02364190","ABSTRAL (fentanyl (fentanyl citrate) 300 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700297","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02309882","PMS-OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02388669","LORAZEPAM INJECTION USP (lorazepam 4 mg per 1 mL solution for injection vial) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00725749","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 100 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02468093","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 16 mg and naloxone (naloxone hydrochloride dihydrate) 4 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700350","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 50 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01901869","SANDOZ OPIUM & BELLADONNA (belladonna 15 mg and opium 65 mg suppository) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02408007","FENTORA (fentanyl (fentanyl citrate) 100 mcg buccal tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02482681","MORPHINE SULFATE INJECTION, USP (morphine sulfate 2 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02041472","ATIVAN (lorazepam 2 mg sublingual tablet) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00535230","CALMYLIN (ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02137267","MORPHINE SULPHATE INJECTION 50MG/ML (morphine sulfate 50 mg per mL solution for injection 50 mL vial) HOSPIRA HEALTHCARE ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02445530","APO-AMPHETAMINE XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) APOTEX INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02172917","CALMYLIN PSE WITH CODEINE (codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02408023","FENTORA (fentanyl (fentanyl citrate) 400 mcg buccal tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02490269","VYVANSE (lisdexamfetamine dimesylate 50 mg chewable tablet) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02245758","PMS-OXYCODONE - ACETAMINOPHEN (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02247174","BIO-DIAZEPAM (diazepam 5 mg oral tablet) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02277158","BIPHENTIN (methylphenidate hydrochloride 20 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01916548","ENDOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700521","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02440393","PMS-AMPHETAMINES XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) PHARMASCIENCE INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02465264","BELBUCA (buprenorphine (buprenorphine hydrochloride) 450 mcg buccal film) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00178802","PHENOBARB (phenobarbital 30 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00632201","STATEX-SUPPOSITORIES 10MG (morphine sulfate 10 mg suppository) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02125382","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG (hydromorphone hydrochloride 24 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700448","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01916386","PMS HYDROMORPHONE SIROP 1MG/ML (hydromorphone hydrochloride 1 mg per mL syrup) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00591467","STATEX SYRUP 1MG/ML (morphine sulfate 1 mg per mL syrup) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700302","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 (hydromorphone hydrochloride 10 mg per 1 mL solution for injection ampoule) STERIMAX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700301","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 (hydromorphone hydrochloride 100 mg per 10 mL solution for injection ampoule) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02295709","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02413736","PMS-METHYLPHENIDATE ER (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700348","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02268272","XYREM (sodium oxybate 500 mg per mL oral solution) JAZZ PHARMACEUTICALS IRELAND LIMITED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476630","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 6 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02330113","RAN-FENTANYL MATRIX PATCH (fentanyl 25 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02220520","BROMAZEPAM-3 - TAB 3MG (bromazepam 3 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02251914","ACETAMINOPHEN, CAFFEINE, AND 8MG OF CODEINE PHOSPHATE TABLETS (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) CELLCHEM PHARMACEUTICALS INC.","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02049481","NOVAHISTEX DH (hydrocodone bitartrate 5 mg per 5 mL and phenylephrine hydrochloride 20 mg per 5 mL syrup) SANOFI-AVENTIS CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00850314","MORPHINE SULFATE INJECTION USP (morphine sulfate 2 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00511528","MOGADON (nitrazepam 5 mg oral tablet) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00522988","CHLORDIAZEPOXIDE (chlordiazepoxide hydrochloride 10 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02450437","TARO-TRAMADOL ER (tramadol hydrochloride 200 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00885401","PMS-HYDROMORPHONE TAB 4MG (hydromorphone hydrochloride 4 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02443236","DEXTROAMPHETAMINE (dextroamphetamine sulfate 5 mg oral tablet) AA PHARMA INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02242163","KADIAN (morphine sulfate 10 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00414220","SOM-PAM (flurazepam hydrochloride 15 mg oral capsule) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02384892","TEVA-NABILONE (nabilone 1 mg oral capsule) TEVA CANADA LIMITED","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02163780","CODEINE CONTIN 150MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 150 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02388308","JAMP-ACET-TRAMADOL (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) JAMP PHARMA CORPORATION","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02366789","APO-OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02138018","DEMEROL (meperidine hydrochloride 50 mg oral tablet) SANOFI-AVENTIS CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01916394","PMS HYDROMORPHONE SUPPOSITOIRE 3MG (hydromorphone hydrochloride 3 mg suppository) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02373017","DURELA (tramadol hydrochloride 100 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02440377","PMS-AMPHETAMINES XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) PHARMASCIENCE INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02019949","M-ESLON (morphine sulfate 30 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394596","METHADOSE (methadone hydrochloride 10 mg per mL oral solution) MALLINCKRODT CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02465248","BELBUCA (buprenorphine (buprenorphine hydrochloride) 150 mcg buccal film) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00593435","TEVA-CODEINE (codeine phosphate 15 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700607","MIDAZOLAM INJECTION (midazolam 10 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02457288","SANDOZ AMPHETAMINE XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700520","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01949055","MORPHINE-EPD (morphine sulfate 5 mg per 5 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02410753","LORAZEPAM SUBLINGUAL (lorazepam 1 mg sublingual tablet) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394197","ACT OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02242504","BUTORPHANOL NASAL SPRAY (butorphanol tartrate 10 mg per mL nasal spray) AA PHARMA INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244080","DIMETANE EXPECTORANT DC (brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02370433","SUBLINOX (zolpidem tartrate 10 mg orodispersible tablet) BAUSCH HEALTH, CANADA INC.","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02230369","CLONAPAM (clonazepam 2 mg oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C.","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700295","HYDROMORPHONE HP 20 (hydromorphone hydrochloride 100 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02311615","PRO-CLONAZEPAM (clonazepam 2 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00392480","SUPEUDOL 10 (oxycodone hydrochloride 10 mg suppository) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02394219","ACT OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02315076","TEVA-METHYLPHENIDATE ER-C (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364115","APO-HYDROMORPHONE (hydromorphone hydrochloride 1 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00834319","ACETAZONE FORTE C8 (acetaminophen 300 mg and chlorzoxazone 250 mg and codeine phosphate 8 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02230769","DALMACOL (alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrin hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00705799","STATEX DPS 50MG/ML (morphine sulfate 50 mg per mL oral drops) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02383209","ACT TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) ACTAVIS PHARMA COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02366746","APO-OXYCODONE CR (oxycodone hydrochloride 5 mg prolonged-release oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02378299","NUCYNTA IR (tapentadol (tapentadol hydrochloride) 100 mg oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700354","MORPHINE SULFATE INJ 2MG/ML USP (morphine sulfate 2 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02417642","NAT-ALPRAZOLAM (alprazolam 0.5 mg oral tablet) NATCO PHARMA (CANADA) INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02393581","ACT NABILONE (nabilone 0.5 mg oral capsule) ACTAVIS PHARMA COMPANY","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700487","FENTANYL CITRATE INJECTION SDZ (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700345","MORPHINE HP 25 - 25MG/ML (morphine sulfate 100 mg per 4 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014238","MS.IR (morphine sulfate 20 mg oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700349","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00647217","STATEX SYRUP 10MG/ML (morphine sulfate 10 mg per mL syrup) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02248127","BIO-FLURAZEPAM (flurazepam hydrochloride 30 mg oral capsule) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02280248","TESTIM 1% (testosterone 1 % transdermal gel 5 g tube) PALADIN LABS INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02327147","SANDOZ FENTANYL PATCH (fentanyl 50 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01999648","ACET CODEINE 30 (acetaminophen 300 mg and codeine phosphate 30 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02395657","FENTANYL PATCH (fentanyl 12 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02396742","MYLAN-FENTANYL MATRIX PATCH (fentanyl 100 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02372584","OXYNEO (oxycodone hydrochloride 80 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02372525","OXYNEO (oxycodone hydrochloride 10 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700068","DIASTAT (diazepam 5 mg per 1 mL rectal gel tube) VALEANT PHARMACEUTICALS NORTH AMERICA LLC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02319985","PMS-OXYCODONE (oxycodone hydrochloride 10 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02125366","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG (hydromorphone hydrochloride 12 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02341395","PMS-FENTANYL MTX (fentanyl 50 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700930","KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02341409","PMS-FENTANYL MTX (fentanyl 75 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02177749","M-ESLON (morphine sulfate 15 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02233960","SANDOZ CLONAZEPAM (clonazepam 0.5 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02413752","PMS-METHYLPHENIDATE ER (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02019957","M-ESLON (morphine sulfate 60 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02299194","RALIVIA (tramadol hydrochloride 100 mg prolonged-release oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02319403","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 1 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02304090","PHENOBARBITAL SODIUM INJECTION, USP (phenobarbital sodium 120 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02410761","LORAZEPAM SUBLINGUAL (lorazepam 2 mg sublingual tablet) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700614","MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 10 mg per 2 mL solution for injection vial) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700958","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 (hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00726362","PMS-OXAZEPAM TAB 10MG (oxazepam 10 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700489","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) TELIGENT OU","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02341174","BUTRANS 5 (buprenorphine 5 mcg per hour transdermal patch) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02247700","METADOL (methadone hydrochloride 10 mg oral tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02415577","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 50 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700304","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02364182","ABSTRAL (fentanyl (fentanyl citrate) 200 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02350912","MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) SANIS HEALTH INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00640409","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 10 mg per mL solution for injection 30 mL vial) ICU MEDICAL CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02177757","M-ESLON (morphine sulfate 200 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01924567","DEXEDRINE SPANSULE SRC 15MG (dextroamphetamine sulfate 15 mg prolonged-release oral capsule) PALADIN LABS INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02442035","CLONAZEPAM (clonazepam 0.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00178799","PHENOBARB (phenobarbital 15 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364158","APO-HYDROMORPHONE (hydromorphone hydrochloride 8 mg oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700341","MORPHINE EXTRA-FORTE (morphine sulfate 50 mg per mL solution for injection 20 mL vial) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02327139","SANDOZ FENTANYL PATCH (fentanyl 37 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00405337","DIAZEPAM (diazepam 10 mg oral tablet) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02470330","FOQUEST (methylphenidate hydrochloride 70 mg modified-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700305","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02395665","FENTANYL PATCH (fentanyl 25 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02282984","TEVA-FENTANYL (fentanyl 100 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700617","MIDAZOLAM INJECTION SDZ (midazolam 2 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02334186","DURAGESIC (fentanyl 12 mcg per hour transdermal patch) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02350815","MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) SANIS HEALTH INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02019965","M-ESLON (morphine sulfate 100 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02347164","VYVANSE (lisdexamfetamine dimesylate 40 mg oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02163926","TYLENOL WITH CODEINE NO. 3 - TAB (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 30 mg oral tablet) JANSSEN INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02382385","MIDAZOLAM INJECTION USP WITH PRESERVATIVE (midazolam 50 mg per 10 mL solution for injection vial) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02417634","NAT-ALPRAZOLAM (alprazolam 0.25 mg oral tablet) NATCO PHARMA (CANADA) INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014327","MS CONTIN SRT 200MG (morphine sulfate 200 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02439050","AURO-TRAMADOL/ACETAMINOPHEN (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) AURO PHARMA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02248706","ALPRAZOLAM (alprazolam 1 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02415585","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 100 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02177153","APO-BROMAZEPAM - TAB 1.5MG (bromazepam 1.5 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700597","MIDAZOLAM INJECTION (midazolam 10 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700605","MIDAZOLAM INJECTION (midazolam 5 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02417669","NAT-ALPRAZOLAM (alprazolam 2 mg oral tablet) NATCO PHARMA (CANADA) INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394170","ACT OXYCODONE CR (oxycodone hydrochloride 5 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02364131","APO-HYDROMORPHONE (hydromorphone hydrochloride 4 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02341417","PMS-FENTANYL MTX (fentanyl 100 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02184443","KADIAN (morphine sulfate 50 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02388197","TARO-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) SUN PHARMA CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01934791","ROBAXISAL C 1/2 (acetylsalicylic acid 325 mg and codeine phosphate 32.4 mg and methocarbamol 400 mg oral tablet) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01971387","TRIANAL C (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244797","HYDROMORPHONE HP FORTE INJECTION (hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01949047","MORPHINE-EPD (morphine sulfate 5 mg per 10 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00518131","LECTOPAM TAB 6MG (bromazepam 6 mg oral tablet) HOFFMANN-LA ROCHE LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476665","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 18 mg prolonged-release oral capsule) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02386143","DIAZEPAM INJECTION SDZ (diazepam 10 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00852163","TRIATEC-8 (acetaminophen 325 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02277174","BIPHENTIN (methylphenidate hydrochloride 30 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02041421","ATIVAN (lorazepam 1 mg oral tablet) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00608181","TEVA-TECNAL C 1/2 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02485540","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 40 mg per 100 mL solution for injection bag) STERINOVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00725757","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 75 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02386895","CO FENTANYL (fentanyl 100 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014319","MS CONTIN SRT 100MG (morphine sulfate 100 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02277131","BIPHENTIN (methylphenidate hydrochloride 15 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02436175","PMS-ZOLPIDEM ODT (zolpidem tartrate 5 mg orodispersible tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700603","MIDAZOLAM INJECTION (midazolam 10 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00594636","STATEX TABLET 25MG (morphine sulfate 25 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700618","MIDAZOLAM INJECTION SDZ (midazolam 5 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700620","MIDAZOLAM INJECTION SDZ (midazolam 50 mg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02396734","MYLAN-FENTANYL MATRIX PATCH (fentanyl 75 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02324628","APO-OXYCODONE/ACET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700450","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02325969","OXYCODONE (oxycodone hydrochloride 10 mg oral tablet) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02242005","DEMEROL 100 MG/ML (meperidine hydrochloride 100 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02273039","PMS-TEMAZEPAM (temazepam 15 mg oral capsule) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02366460","REMIFENTANIL HYDROCHLORIDE FOR INJECTION (remifentanil (remifentanil hydrochloride) 1 mg per vial powder for solution for injection) STERIMAX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700347","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02230302","CODEINE CONTIN 50MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 50 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02394618","METHADOSE DYE FREE, SUGAR FREE, UNFLAVORED (methadone hydrochloride 10 mg per mL oral solution) MALLINCKRODT CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00125083","DILAUDID (hydromorphone hydrochloride 2 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00125121","DILAUDID (hydromorphone hydrochloride 4 mg oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00655759","APO-LORAZEPAM TAB 1MG (lorazepam 1 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02386879","CO FENTANYL (fentanyl 50 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02247173","BIO-DIAZEPAM (diazepam 2 mg oral tablet) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01916963","TUSSIONEX (hydrocodone 5 mg and phenyltoloxamine 10 mg prolonged-release oral tablet) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02404885","RIVA-ALPRAZOLAM (alprazolam 0.5 mg oral tablet) LABORATOIRE RIVA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00607770","RATIO-MORPHINE (morphine hydrochloride 5 mg per mL syrup) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02234749","PMS-METHYLPHENIDATE (methylphenidate hydrochloride 5 mg oral tablet) PHARMASCIENCE INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394200","ACT OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02325950","OXYCODONE (oxycodone hydrochloride 5 mg oral tablet) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02417650","NAT-ALPRAZOLAM (alprazolam 1 mg oral tablet) NATCO PHARMA (CANADA) INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00392588","MORPHINE SULFATE INJ 10MG/ML USP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02439239","ACT AMPHETAMINE XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) TEVA CANADA LIMITED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700067","DIASTAT (diazepam 2.5 mg per 0.5 mL rectal gel tube) VALEANT PHARMACEUTICALS NORTH AMERICA LLC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02282968","TEVA-FENTANYL (fentanyl 50 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02463792","TARO-TESTOSTERONE GEL 2.5G/PACKET (testosterone 1 % transdermal gel 2.5 g sachet) TARO PHARMACEUTICALS INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476657","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 12 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02339625","TARGIN (naloxone hydrochloride 20 mg and oxycodone hydrochloride 40 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01916599","HYCODAN TABLETS (hydrocodone bitartrate 5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02014300","MS CONTIN SRT 60MG (morphine sulfate 60 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02230102","TEVA-TEMAZEPAM (temazepam 30 mg oral capsule) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02238645","292 TABLETS (acetylsalicylic acid 375 mg and caffeine (caffeine citrate) 15 mg and codeine phosphate 30 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700599","MIDAZOLAM INJECTION (midazolam 5 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02400138","JAMP-ALPRAZOLAM (alprazolam 0.5 mg oral tablet) JAMP PHARMA CORPORATION","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00614491","DOLORAL 1 (morphine hydrochloride 1 mg per mL syrup) LABORATOIRE ATLAS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00392472","SUPEUDOL 20 (oxycodone hydrochloride 20 mg suppository) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02408058","FENTORA (fentanyl (fentanyl citrate) 800 mcg buccal tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00850330","MORPHINE SULFATE INJECTION USP (morphine sulfate 15 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02048736","PMS-CLONAZEPAM TAB 2MG (clonazepam 2 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02320398","M-EDIAT (morphine sulfate 5 mg oral capsule) ETHYPHARM INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02347172","VYVANSE (lisdexamfetamine dimesylate 60 mg oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02400154","JAMP-ALPRAZOLAM (alprazolam 2 mg oral tablet) JAMP PHARMA CORPORATION","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00443948","SUPEUDOL 10 (oxycodone hydrochloride 10 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02393603","ACT NABILONE (nabilone 1 mg oral capsule) ACTAVIS PHARMA COMPANY","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02395703","FENTANYL PATCH (fentanyl 100 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02415615","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 250 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00636908","MORPHINE SULFATE INJECTION USP (morphine sulfate 30 mg per 30 mL solution for injection vial) ICU MEDICAL CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01999656","ACET CODEINE 60 (acetaminophen 300 mg and codeine phosphate 60 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00667102","PMS-FLURAZEPAM CAP 15MG (flurazepam hydrochloride 15 mg oral capsule) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00594652","STATEX TAB 5MG (morphine sulfate 5 mg oral tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00608165","TEVA-OXYCOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700343","MORPHINE FORTE (morphine sulfate 100 mg per 4 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02424878","PMS-BUPRENORPHINE-NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02009889","CODEINE 15 (codeine phosphate 15 mg oral tablet) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00789739","SUPEUDOL 5 (oxycodone hydrochloride 5 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00414255","OXPAM (oxazepam 15 mg oral tablet) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01916580","HYCODAN SYRUP (hydrocodone bitartrate 5 mg per 5 mL syrup) BRISTOL-MYERS SQUIBB CANADA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700517","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00607762","RATIO-MORPHINE (morphine hydrochloride 1 mg per mL syrup) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02315092","TEVA-METHYLPHENIDATE ER-C (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476673","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 24 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00885444","PMS-HYDROMORPHONE TAB 1MG (hydromorphone hydrochloride 1 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02302780","TEVA-MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00584991","PMS-METHYLPHENIDATE (methylphenidate hydrochloride 10 mg oral tablet) PHARMASCIENCE INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02311607","PRO-CLONAZEPAM (clonazepam 1 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02145901","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700449","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02179660","PMS-CLONAZEPAM- TAB 0.25MG (clonazepam 0.25 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476649","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 9 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02270676","CO CLONAZEPAM (clonazepam 2 mg oral tablet) COBALT PHARMACEUTICALS COMPANY","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00860689","CLORAZEPATE (clorazepate dipotassium 3.75 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02248811","ADDERALL XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02327155","SANDOZ FENTANYL PATCH (fentanyl 75 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02337282","JURNISTA (hydromorphone hydrochloride 16 mg prolonged-release oral tablet) JANSSEN INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02266687","APO-METHYLPHENIDATE SR (methylphenidate hydrochloride 20 mg prolonged-release oral tablet) APOTEX INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02468468","HYDROMORPHONE HYDROCHLORIDE INJECTION HP FORTE (hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial) STERIMAX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00548359","XANAX (alprazolam 0.25 mg oral tablet) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02470322","FOQUEST (methylphenidate hydrochloride 55 mg modified-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02237420","ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247699","METADOL (methadone hydrochloride 5 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02240131","OXY.IR (oxycodone hydrochloride 10 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02015439","MS CONTIN SRT 15MG (morphine sulfate 15 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00850322","MORPHINE SULFATE INJECTION USP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00585009","PMS-METHYLPHENIDATE (methylphenidate hydrochloride 20 mg oral tablet) PHARMASCIENCE INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02396696","MYLAN-FENTANYL MATRIX PATCH (fentanyl 12 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02256193","CESAMET (nabilone 0.5 mg oral capsule) BAUSCH HEALTH, CANADA INC.","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02395681","FENTANYL PATCH (fentanyl 75 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02481979","SANDOZ METHADONE (methadone hydrochloride 10 mg per mL oral solution) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02364204","ABSTRAL (fentanyl (fentanyl citrate) 400 mcg sublingual tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02233982","SANDOZ CLONAZEPAM (clonazepam 1 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02242504","BUTORPHANOL NASAL SPRAY (butorphanol tartrate 10 mg per mL nasal spray) AA PHARMA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02445514","APO-AMPHETAMINE XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) APOTEX INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02314630","APO-FENTANYL MATRIX (fentanyl 25 mcg per hour transdermal patch) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02330156","RAN-FENTANYL MATRIX PATCH (fentanyl 100 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02163918","TYLENOL WITH CODEINE NO. 4 (acetaminophen 300 mg and codeine phosphate 60 mg oral tablet) JANSSEN INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02248808","ADDERALL XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700298","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476622","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01996541","ACETAMINOPHENE CODEINE ET CAFEINE CAPLETS (acetaminophen 325 mg and caffeine citrate 30 mg and codeine phosphate 8 mg oral tablet) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02483084","SUBLOCADE (buprenorphine 100 mg per 0.5 mL prolonged-release solution for injection syringe) INDIVIOR UK LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01966367","METHOXISAL-C 1/4 (acetylsalicylic acid 325 mg and codeine phosphate 16.2 mg and methocarbamol 400 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02441969","ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) ACTAVIS PHARMA COMPANY","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02049473","NOVAHISTINE DH (hydrocodone bitartrate 1.7 mg per 5 mL and phenylephrine hydrochloride 10 mg per 5 mL syrup) SANOFI-AVENTIS CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02327171","OXYCODONE-ACET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) PRO DOC LIMITEE","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014211","MS.IR (morphine sulfate 10 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02341379","PMS-FENTANYL MTX (fentanyl 12 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02232658","PROCET-30 (acetaminophen 300 mg and codeine phosphate 30 mg oral tablet) PRO DOC LIMITEE","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02230095","TEVA-TEMAZEPAM (temazepam 15 mg oral capsule) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700447","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00521698","FLURAZEPAM (flurazepam hydrochloride 15 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02314665","APO-FENTANYL MATRIX (fentanyl 100 mcg per hour transdermal patch) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02319438","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 4 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02424851","PMS-BUPRENORPHINE-NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02242468","RIVACOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) LABORATOIRE RIVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700303","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01934740","ROBITUSSIN AC (codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pheniramine maleate 7.5 mg per 5 mL syrup) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02372576","OXYNEO (oxycodone hydrochloride 60 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02319446","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 8 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00786543","DILAUDID (hydromorphone hydrochloride 8 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02408104","MYLAN-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) MYLAN PHARMACEUTICALS ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02243562","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG (hydromorphone hydrochloride 18 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244790","SANDOZ MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02396718","MYLAN-FENTANYL MATRIX PATCH (fentanyl 25 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02322951","VYVANSE (lisdexamfetamine dimesylate 30 mg oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247374","METADOL-D (methadone hydrochloride 1 mg per mL oral solution) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02360322","ZYTRAM XL (tramadol hydrochloride 75 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700625","MIDAZOLAM INJECTION (midazolam 15 mg per 3 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00544884","CODEINE PHOSPHATE INJECTION USP (codeine phosphate 30 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02163934","TYLENOL WITH CODEINE NO. 2 - TAB (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 15 mg oral tablet) JANSSEN INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02021048","MORPHINE LP EPIDURAL (morphine sulfate 5 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02309890","PMS-OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00608882","TEVA-EMTEC-30 (acetaminophen 300 mg and codeine phosphate 30 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02341387","PMS-FENTANYL MTX (fentanyl 25 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00632775","RITALIN-SR TAB 20MG (methylphenidate hydrochloride 20 mg prolonged-release oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02224577","COPHYLAC (normethadone hydrochloride 10 mg per mL and p-hydroxyephedrine hydrochloride 20 mg per mL oral drops) BAUSCH HEALTH, CANADA INC.","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02465221","BELBUCA (buprenorphine (buprenorphine hydrochloride) 75 mcg buccal film) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00226327","FIORINAL (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule) ARALEZ PHARMACEUTICALS CANADA INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700857","SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02359502","HYDROMORPH CONTIN (hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02137534","MYLAN-ALPRAZOLAM (alprazolam 0.25 mg oral tablet) MYLAN PHARMACEUTICALS ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700291","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02245784","DOM-LORAZEPAM (lorazepam 0.5 mg oral tablet) DOMINION PHARMACAL","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02339609","TARGIN (naloxone hydrochloride 5 mg and oxycodone hydrochloride 10 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02408090","MYLAN-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) MYLAN PHARMACEUTICALS ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014297","MS CONTIN SRT 30MG (morphine sulfate 30 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00705438","DILAUDID (hydromorphone hydrochloride 1 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02366754","APO-OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02009757","CODEINE 30 (codeine phosphate 30 mg oral tablet) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02304082","PHENOBARBITAL SODIUM INJECTION, USP (phenobarbital sodium 30 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01934783","ROBAXISAL C 1/4 (acetylsalicylic acid 325 mg and codeine phosphate 16.2 mg and methocarbamol 400 mg oral tablet) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02242077","RIVA-CLONAZEPAM (clonazepam 0.5 mg oral tablet) LABORATOIRE RIVA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02277204","BIPHENTIN (methylphenidate hydrochloride 60 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700353","MORPHINE SULFATE INJ 1MG/ML USP (morphine sulfate 5 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01916491","PERCOCET-DEMI (acetaminophen 325 mg and oxycodone hydrochloride 2.5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700358","MORPHINE SULPHATE INJECTION 1MG/ML (morphine sulfate 1 mg per mL solution for injection 50 mL vial) HOSPIRA HEALTHCARE ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394189","ACT OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02302772","TEVA-MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00293512","ATASOL 30 (acetaminophen 325 mg and caffeine citrate 30 mg and codeine phosphate 30 mg oral tablet) CHURCH & DWIGHT CANADA CORP","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01964429","MORPHINE SULFATE INJ 5MG/ML USP (morphine sulfate 5 mg per mL solution for injection 30 mL vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700294","HYDROMORPHONE HP 20 (hydromorphone hydrochloride 20 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02231934","OXY.IR (oxycodone hydrochloride 5 mg oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02330121","RAN-FENTANYL MATRIX PATCH (fentanyl 50 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02247694","METADOL (methadone hydrochloride 1 mg per mL oral solution) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02137240","MORPHINE SULPHATE INJECTION 2MG/ML (morphine sulfate 2 mg per mL solution for injection 50 mL vial) HOSPIRA HEALTHCARE ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02386852","CO FENTANYL (fentanyl 25 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02021056","MORPHINE LP EPIDURAL (morphine sulfate 5 mg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02360349","ZYTRAM XL (tramadol hydrochloride 100 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00813958","XANAX TS (alprazolam 2 mg oral tablet) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02282976","TEVA-FENTANYL (fentanyl 75 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00518123","LECTOPAM TAB 3MG (bromazepam 3 mg oral tablet) HOFFMANN-LA ROCHE LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700290","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 100 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00690074","COUGH SYRUP (ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02366479","REMIFENTANIL HYDROCHLORIDE FOR INJECTION (remifentanil (remifentanil hydrochloride) 2 mg per vial powder for solution for injection) STERIMAX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02302799","TEVA-MORPHINE SR (morphine sulfate 100 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02408015","FENTORA (fentanyl (fentanyl citrate) 200 mcg buccal tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700299","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244792","SANDOZ MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02361361","OXYCODONE/ACET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) SANIS HEALTH INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00036323","LOMOTIL (atropine sulfate 0.025 mg and diphenoxylate hydrochloride 2.5 mg oral tablet) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02391554","PRIVA-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) PHARMAPAR INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02230321","RATIO-METHYLPHENIDATE (methylphenidate hydrochloride 10 mg oral tablet) TEVA CANADA LIMITED","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02339617","TARGIN (naloxone hydrochloride 10 mg and oxycodone hydrochloride 20 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02137984","TALWIN (pentazocine (pentazocine hydrochloride) 50 mg oral tablet) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02248812","ADDERALL XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02372797","OXYNEO (oxycodone hydrochloride 20 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00621935","STATEX DROPS 20MG/ML (morphine sulfate 20 mg per mL oral drops) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02378280","NUCYNTA IR (tapentadol (tapentadol hydrochloride) 75 mg oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02474921","PROBUPHINE (buprenorphine hydrochloride 80 mg implant) KNIGHT THERAPEUTICS INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02295695","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00885428","PMS-HYDROMORPHONE TAB 8MG (hydromorphone hydrochloride 8 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02337274","JURNISTA (hydromorphone hydrochloride 8 mg prolonged-release oral tablet) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02396726","MYLAN-FENTANYL MATRIX PATCH (fentanyl 50 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700931","KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 100 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02453703","WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) JAMP PHARMA CORPORATION","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700340","MORPHINE EXTRA-FORTE (morphine sulfate 50 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02315068","TEVA-METHYLPHENIDATE ER-C (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02314649","APO-FENTANYL MATRIX (fentanyl 50 mcg per hour transdermal patch) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02476614","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 3 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02404877","RIVA-ALPRAZOLAM (alprazolam 0.25 mg oral tablet) LABORATOIRE RIVA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02275856","DURAGESIC (fentanyl 100 mcg per hour transdermal patch) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02246085","ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE TABLETS (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) JAMP PHARMA CORPORATION","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00497282","CODEINE PHOSPHATE INJ 30MG/ML (codeine phosphate 30 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02372533","OXYNEO (oxycodone hydrochloride 15 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700351","MORPHINE SULFATE INJ 1MG/ML USP (morphine sulfate 10 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02273047","PMS-TEMAZEPAM (temazepam 30 mg oral capsule) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02408031","FENTORA (fentanyl (fentanyl citrate) 600 mcg buccal tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02319993","PMS-OXYCODONE (oxycodone hydrochloride 20 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02327112","SANDOZ FENTANYL PATCH (fentanyl 12 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02349191","ALPRAZOLAM (alprazolam 0.25 mg oral tablet) SANIS HEALTH INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02243978","PMS-CODEINE (codeine phosphate 15 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02286459","ZYTRAM XL (tramadol hydrochloride 400 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00808571","TRIAZOLAM (triazolam 0.25 mg oral tablet) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700071","DIASTAT (diazepam 20 mg per 4 mL rectal gel tube) VALEANT PHARMACEUTICALS NORTH AMERICA LLC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00690791","RATIO-MORPHINE (morphine hydrochloride 20 mg per mL syrup) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700296","HYDROMORPHONE HP 20 (hydromorphone hydrochloride 20 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00050024","CODEINE PHOSPHATE SYRUP (codeine phosphate 25 mg per 5 mL syrup) LABORATOIRE ATLAS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00497770","OXAZEPAM 30 TAB 30MG (oxazepam 30 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364220","ABSTRAL (fentanyl (fentanyl citrate) 800 mcg sublingual tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700901","SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule) STERIMAX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02241377","METADOL (methadone hydrochloride 10 mg per mL oral solution) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02230322","RATIO-METHYLPHENIDATE (methylphenidate hydrochloride 20 mg oral tablet) TEVA CANADA LIMITED","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02131013","DOM-CLONAZEPAM - TAB 2MG (clonazepam 2 mg oral tablet) DOMINION PHARMACAL","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02373033","DURELA (tramadol hydrochloride 300 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00632228","STATEX SUPPOSITORIES 5MG (morphine sulfate 5 mg suppository) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700516","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00497290","CODEINE PHOSPHATE INJ 60MG/ML (codeine phosphate 60 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00621463","TEVA-LENOLTEC NO. 4 (acetaminophen 300 mg and codeine phosphate 60 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02273950","APO-METHYLPHENIDATE (methylphenidate hydrochloride 5 mg oral tablet) APOTEX INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02309904","PMS-OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02366762","APO-OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700356","MORPHINE SULFATE INJECTION SDZ (morphine sulfate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394782","APO-OXYCODONE CR (oxycodone hydrochloride 60 mg prolonged-release oral tablet) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02240132","OXY.IR (oxycodone hydrochloride 20 mg oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02359510","HYDROMORPH CONTIN (hydromorphone hydrochloride 9 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02439271","ACT AMPHETAMINE XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) TEVA CANADA LIMITED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02450771","BUTRANS 15 (buprenorphine 15 mcg per hour transdermal patch) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02474980","MORPHINE SULFATE INJECTION BP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) STERIMAX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02177188","APO-BROMAZEPAM - TAB 6MG (bromazepam 6 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02468085","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride dihydrate) 3 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02242003","DEMEROL 50 MG/ML   (SINGLE USE, PRESERVATIVE FREE) (meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02442027","CLONAZEPAM (clonazepam 0.25 mg oral tablet) SIVEM PHARMACEUTICALS ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700292","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02470314","FOQUEST (methylphenidate hydrochloride 45 mg modified-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02325977","OXYCODONE (oxycodone hydrochloride 20 mg oral tablet) PRO DOC LIMITEE","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02439263","ACT AMPHETAMINE XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) TEVA CANADA LIMITED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00029246","DELATESTRYL (testosterone enanthate 1000 mg per 5 mL solution for injection ampoule) BAUSCH HEALTH, CANADA INC.","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700595","MIDAZOLAM INJECTION (midazolam 5 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02303299","AC&C TABLETS (acetylsalicylic acid 375 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02306530","APO-OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02314657","APO-FENTANYL MATRIX (fentanyl 75 mcg per hour transdermal patch) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02319411","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 2 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02364212","ABSTRAL (fentanyl (fentanyl citrate) 600 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700357","MORPHINE SULFATE INJECTION SDZ (morphine sulfate 50 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02302802","TEVA-MORPHINE SR (morphine sulfate 200 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700451","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 2500 mcg per 50 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00675962","STATEX TABLETS 50MG (morphine sulfate 50 mg oral tablet) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00690783","RATIO-MORPHINE (morphine hydrochloride 10 mg per mL syrup) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02452758","APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) APOTEX INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364174","ABSTRAL (fentanyl (fentanyl citrate) 100 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02324253","PDP-HYDROCODONE (hydrocodone bitartrate 5 mg per 5 mL syrup) PENDOPHARM DIVISION OF PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02330148","RAN-FENTANYL MATRIX PATCH (fentanyl 75 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700488","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) TELIGENT OU","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02465256","BELBUCA (buprenorphine (buprenorphine hydrochloride) 300 mcg buccal film) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02434946","APO-ZOLPIDEM ODT (zolpidem tartrate 10 mg orodispersible tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02163799","CODEINE CONTIN 200MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 200 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02320436","M-EDIAT (morphine sulfate 20 mg oral capsule) ETHYPHARM INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02349205","ALPRAZOLAM (alprazolam 0.5 mg oral tablet) SANIS HEALTH INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00414263","OXPAM (oxazepam 30 mg oral tablet) BIOMED PHARMA","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02262983","SUPEUDOL (oxycodone hydrochloride 20 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00637742","TEVA-LORAZEPAM (lorazepam 1 mg oral tablet) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244290","METADOL-D (methadone hydrochloride 10 mg per mL oral solution) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00402680","APO OXAZEPAM TAB 10MG (oxazepam 10 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02243612","APO-ALPRAZ TS (alprazolam 2 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02327120","SANDOZ FENTANYL PATCH (fentanyl 25 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02372568","OXYNEO (oxycodone hydrochloride 40 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02476681","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 30 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02242006","DEMEROL 100 MG/ML (meperidine hydrochloride 100 mg per mL solution for injection 20 mL vial) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02453908","ACT BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02125390","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG (hydromorphone hydrochloride 30 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02429969","TRAMADOL / ACETAMINOPHEN (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02341220","BUTRANS 20 (buprenorphine 20 mcg per hour transdermal patch) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02386844","CO FENTANYL (fentanyl 12 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00645575","PHENOBARB ELIXIR (phenobarbital 5 mg per mL oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00865397","APO-ALPRAZ (alprazolam 0.25 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700957","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 (hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02163748","CODEINE CONTIN 100MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 100 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00594644","STATEX TAB 10MG (morphine sulfate 10 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00723770","XANAX TAB 1MG (alprazolam 1 mg oral tablet) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02387425","TARGIN (naloxone hydrochloride 2.5 mg and oxycodone hydrochloride 5 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02302764","TEVA-MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00655643","PRO-LORAZEPAM (lorazepam 0.5 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02388324","MAR-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) MARCAN PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02242484","MORPHINE SULFATE INJECTION USP (morphine sulfate 2 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00178810","PHENOBARB (phenobarbital 60 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02242078","RIVA-CLONAZEPAM (clonazepam 2 mg oral tablet) LABORATOIRE RIVA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02309912","PMS-OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02486903","COUGH AND ALLERGY SYRUP WITH CODEINE (ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup) LABORATOIRE RIVA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02230368","CLONAPAM (clonazepam 1 mg oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C.","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02245346","ANDROGEL (testosterone 1 % transdermal gel 5 g sachet) BGP PHARMA ULC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02415593","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 150 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02221799","FRISIUM TABLET 10MG (clobazam 10 mg oral tablet) LUNDBECK PHARMACEUTICALS LLC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02341212","BUTRANS 10 (buprenorphine 10 mcg per hour transdermal patch) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700486","FENTANYL CITRATE INJECTION SDZ (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00392561","MORPHINE SULFATE INJ 15MG/ML USP (morphine sulfate 15 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00608157","TEVA-OXYCODAN (acetylsalicylic acid 325 mg and oxycodone hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00596965","STATEX SUPPOSITORIES 20MG (morphine sulfate 20 mg suppository) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02184451","KADIAN (morphine sulfate 100 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02394766","APO-OXYCODONE CR (oxycodone hydrochloride 15 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700342","MORPHINE EXTRA-FORTE (morphine sulfate 50 mg per mL solution for injection 50 mL vial) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700352","MORPHINE SULFATE INJ 1MG/ML USP (morphine sulfate 1 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00293504","ATASOL 15 (acetaminophen 325 mg and caffeine citrate 30 mg and codeine phosphate 15 mg oral tablet) CHURCH & DWIGHT CANADA CORP","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00725765","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02395673","FENTANYL PATCH (fentanyl 50 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02469650","NRA-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) NORA PHARMA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00548367","XANAX TAB 0.5MG (alprazolam 0.5 mg oral tablet) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700300","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02229814","MYLAN-ALPRAZOLAM (alprazolam 2 mg oral tablet) MYLAN PHARMACEUTICALS ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02351072","LORAZEPAM (lorazepam 0.5 mg oral tablet) SANIS HEALTH INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02099748","COUGH SYRUP WITH CODEINE (codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00180041","A.C. & C 8MG TAB (acetylsalicylic acid 375 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) VITA HEALTH PRODUCTS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02275813","DURAGESIC (fentanyl 25 mcg per hour transdermal patch) JANSSEN INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02364123","APO-HYDROMORPHONE (hydromorphone hydrochloride 2 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00507407","DALMACOL (alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrin hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup) LABORATOIRE ATLAS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700293","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02275821","DURAGESIC (fentanyl 50 mcg per hour transdermal patch) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02242004","DEMEROL 75 MG/ML (meperidine hydrochloride 75 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02019930","M-ESLON (morphine sulfate 10 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00380571","LINCTUS CODEINE BLANC (codeine phosphate 10 mg per 5 mL oral solution) LABORATOIRE ATLAS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02350890","MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) SANIS HEALTH INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700518","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700611","MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 5 mg per 5 mL solution for injection vial) PFIZER CANADA ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02436183","PMS-ZOLPIDEM ODT (zolpidem tartrate 10 mg orodispersible tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02478897","SANDOZ MORPHINE SR (morphine sulfate 200 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02239653","ANDRODERM (testosterone 2.5 mg per 24 hour transdermal patch) ALLERGAN INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02282941","TEVA-FENTANYL (fentanyl 25 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02236872","METHOXACET-C 1/8 (acetaminophen 325 mg and codeine phosphate 8 mg and methocarbamol 400 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02234003","SANDOZ NITRAZEPAM (nitrazepam 5 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02248809","ADDERALL XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02450445","TARO-TRAMADOL ER (tramadol hydrochloride 300 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02445506","APO-AMPHETAMINE XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) APOTEX INC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01916971","TUSSIONEX (hydrocodone 5 mg per 5 mL and phenyltoloxamine 10 mg per 5 mL oral suspension) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02378272","NUCYNTA IR (tapentadol (tapentadol hydrochloride) 50 mg oral tablet) ENDO VENTURES LTD","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014203","MS.IR (morphine sulfate 5 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02207818","PMS-CLONAZEPAM-R (clonazepam 0.5 mg oral tablet) PHARMASCIENCE INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02245230","APO-NITRAZEPAM TABLETS BP (nitrazepam 5 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02478889","SANDOZ MORPHINE SR (morphine sulfate 100 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014254","MS.IR (morphine sulfate 30 mg oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02457318","SANDOZ AMPHETAMINE XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02386887","CO FENTANYL (fentanyl 75 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00639389","STATEX SUPPOSITORIES 30MG (morphine sulfate 30 mg suppository) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02311925","TEVA-FENTANYL (fentanyl 12 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02243979","PMS-CODEINE (codeine phosphate 30 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00176141","BELLERGAL SPACETABS (belladonna 0.2 mg and ergotamine tartrate 0.6 mg and phenobarbital 40 mg prolonged-release oral tablet) PALADIN LABS INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00593451","TEVA-CODEINE (codeine phosphate 30 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02277190","BIPHENTIN (methylphenidate hydrochloride 50 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00522996","CHLORDIAZEPOXIDE (chlordiazepoxide hydrochloride 25 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02248454","CLOBAZAM-10 (clobazam 10 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700519","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02460602","HYDROMORPHONE HYDROCHLORIDE INJECTION (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) STERIMAX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02470357","FOQUEST (methylphenidate hydrochloride 100 mg modified-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00649619","MORPHINE SULFATE INJECTION USP (morphine sulfate 150 mg per 30 mL solution for injection vial) ICU MEDICAL CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02344432","REMIFENTANIL FOR INJECTION (remifentanil (remifentanil hydrochloride) 2 mg per vial powder for solution for injection) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02452766","APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) APOTEX INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00653233","TEVA-LENOLTEC NO. 1 (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02400111","JAMP-ALPRAZOLAM (alprazolam 0.25 mg oral tablet) JAMP PHARMA CORPORATION","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02421186","TARO-TESTOSTERONE (testosterone undecanoate 40 mg oral capsule) TARO PHARMACEUTICALS INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00176192","FIORINAL-C 1/4 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule) ARALEZ PHARMACEUTICALS CANADA INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01913484","TEVA-ALPRAZOLAM (alprazolam 0.25 mg oral tablet) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01901869","SANDOZ OPIUM & BELLADONNA (belladonna 15 mg and opium 65 mg suppository) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700350","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 50 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02245785","DOM-LORAZEPAM (lorazepam 1 mg oral tablet) DOMINION PHARMACAL","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02442051","CLONAZEPAM (clonazepam 2 mg oral tablet) SIVEM PHARMACEUTICALS ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02457342","SANDOZ AMPHETAMINE XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700297","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02468093","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 16 mg and naloxone (naloxone hydrochloride dihydrate) 4 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02408023","FENTORA (fentanyl (fentanyl citrate) 400 mcg buccal tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"01916548","ENDOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02137267","MORPHINE SULPHATE INJECTION 50MG/ML (morphine sulfate 50 mg per mL solution for injection 50 mL vial) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00632201","STATEX-SUPPOSITORIES 10MG (morphine sulfate 10 mg suppository) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700448","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02479672","AURO-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) AURO PHARMA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00522724","CHLORDIAZEPOXIDE (chlordiazepoxide hydrochloride 5 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700521","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700598","MIDAZOLAM INJECTION (midazolam 10 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700348","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02476630","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 6 mg prolonged-release oral capsule) APOTEX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00591467","STATEX SYRUP 1MG/ML (morphine sulfate 1 mg per mL syrup) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700301","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 (hydromorphone hydrochloride 100 mg per 10 mL solution for injection ampoule) STERIMAX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700344","MORPHINE FORTE (morphine sulfate 25 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00885436","PMS-HYDROMORPHONE TAB 2MG (hydromorphone hydrochloride 2 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02137542","MYLAN-ALPRAZOLAM (alprazolam 0.5 mg oral tablet) MYLAN PHARMACEUTICALS ULC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02319977","PMS-OXYCODONE (oxycodone hydrochloride 5 mg oral tablet) PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02125323","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG (hydromorphone hydrochloride 3 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02326256","METHYLPHENIDATE (methylphenidate hydrochloride 20 mg oral tablet) PRO DOC LIMITEE","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02241976","TALWIN (pentazocine (pentazocine lactate) 30 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02320444","M-EDIAT (morphine sulfate 30 mg oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02125331","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG (hydromorphone hydrochloride 6 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02277182","BIPHENTIN (methylphenidate hydrochloride 40 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02483092","SUBLOCADE (buprenorphine 300 mg per 1.5 mL prolonged-release solution for injection syringe) INDIVIOR UK LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02404907","RIVA-ALPRAZOLAM (alprazolam 2 mg oral tablet) LABORATOIRE RIVA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02307898","SANDOZ OXYCODONE/ACETAMINOPHEN (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02327163","SANDOZ FENTANYL PATCH (fentanyl 100 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700355","MORPHINE SULFATE INJ 2MG/ML USP (morphine sulfate 2 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02177161","APO-BROMAZEPAM - TAB 3MG (bromazepam 3 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700616","MIDAZOLAM INJECTION SDZ (midazolam 5 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700359","MORPHINE SULPHATE INJECTION 1MG/ML (morphine sulfate 5 mg per 5 mL solution for injection vial) HOSPIRA HEALTHCARE ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02389800","MINT-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) MINT PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700596","MIDAZOLAM INJECTION (midazolam 2 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700354","MORPHINE SULFATE INJ 2MG/ML USP (morphine sulfate 2 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700295","HYDROMORPHONE HP 20 (hydromorphone hydrochloride 100 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00705799","STATEX DPS 50MG/ML (morphine sulfate 50 mg per mL oral drops) PALADIN LABS INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00647217","STATEX SYRUP 10MG/ML (morphine sulfate 10 mg per mL syrup) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02395657","FENTANYL PATCH (fentanyl 12 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700345","MORPHINE HP 25 - 25MG/ML (morphine sulfate 100 mg per 4 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700487","FENTANYL CITRATE INJECTION SDZ (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02143933","ACETAMINOPHEN WITH CODEINE - CAPLET (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014238","MS.IR (morphine sulfate 20 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00568406","RIVA OXAZEPAM (oxazepam 15 mg oral tablet) LABORATOIRE RIVA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00578479","FLURAZEPAM 15 (flurazepam hydrochloride 15 mg oral capsule) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02237578","SPASMHALT-8 (acetaminophen 325 mg and codeine phosphate 8 mg and methocarbamol 400 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02336790","APO-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"77700069","DIASTAT (diazepam 7.5 mg per 1.5 mL rectal gel tube) VALEANT PHARMACEUTICALS NORTH AMERICA LLC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02341395","PMS-FENTANYL MTX (fentanyl 50 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02319985","PMS-OXYCODONE (oxycodone hydrochloride 10 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02372584","OXYNEO (oxycodone hydrochloride 80 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02439603","VYVANSE (lisdexamfetamine dimesylate 10 mg oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700958","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 (hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial) STERIMAX INC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02319403","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 1 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02245231","APO-NITRAZEPAM TABLETS BP (nitrazepam 10 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00850314","MORPHINE SULFATE INJECTION USP (morphine sulfate 2 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02296411","TRIDURAL (tramadol hydrochloride 300 mg prolonged-release oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02049481","NOVAHISTEX DH (hydrocodone bitartrate 5 mg per 5 mL and phenylephrine hydrochloride 20 mg per 5 mL syrup) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02239025","TEVA-CLONAZEPAM (clonazepam 2 mg oral tablet) TEVA CANADA LIMITED","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02230366","CLONAPAM (clonazepam 0.5 mg oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C.","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02163780","CODEINE CONTIN 150MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 150 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00655678","PRO-LORAZEPAM TAB 2MG (lorazepam 2 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02138018","DEMEROL (meperidine hydrochloride 50 mg oral tablet) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00885401","PMS-HYDROMORPHONE TAB 4MG (hydromorphone hydrochloride 4 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02225972","TEMAZEPAM (temazepam 30 mg oral capsule) AA PHARMA INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01916394","PMS HYDROMORPHONE SUPPOSITOIRE 3MG (hydromorphone hydrochloride 3 mg suppository) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00593435","TEVA-CODEINE (codeine phosphate 15 mg oral tablet) TEVA CANADA LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02394596","METHADOSE (methadone hydrochloride 10 mg per mL oral solution) MALLINCKRODT CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02441950","ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) ACTAVIS PHARMA COMPANY","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"77700856","SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02248813","ADDERALL XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) SHIRE PHARMA CANADA ULC","MP","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244080","DIMETANE EXPECTORANT DC (brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244508","PMS-BUTORPHANOL (butorphanol tartrate 10 mg per mL nasal spray) PHARMASCIENCE INC","MP","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"01949047","MORPHINE-EPD (morphine sulfate 5 mg per 10 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02244797","HYDROMORPHONE HP FORTE INJECTION (hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02417502","TRAMADOL-ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"02243611","APO-ALPRAZ (alprazolam 1 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00434388","DIAZEPAM 10TAB 10MG (diazepam 10 mg oral tablet) PRO DOC LIMITEE","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00725757","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 75 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"00402737","APO OXAZEPAM TAB 30MG (oxazepam 30 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02014319","MS CONTIN SRT 100MG (morphine sulfate 100 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02386895","CO FENTANYL (fentanyl 100 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919"
"00655767","APO-LORAZEPAM TAB 2MG (lorazepam 2 mg oral tablet) APOTEX INC","MP","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02392925","TEVA-NABILONE (nabilone 0.25 mg oral capsule) TEVA CANADA LIMITED","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
"02247732","CONCERTA (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) JANSSEN INC","MP","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919"
